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Feed intake is one of the major factors that determine the profitability of livestock 
production. The physiological processes that result in hunger and satiety have been the 
focus of extensive research, but the specific differences in genotype which contribute to 
the variation in appetite in animal populations remain largely unknown. Genetic variation 
in the control of hunger and satiety originates from differences in genes that encode the 
proteins involved. Evaluation of candidate proteins in populations that differ only in their 
genetic propensity to eat may lead to the identification of the responsible genes and 
regulatory sequences. 
Pigs have been a useful model species for studying appetite and related obesity 
(Anika et al., 1981; Houpt et al., 1979). Diverse selection lines of pigs have been studied 
to understand genetic variation in obesity (Wangsness et al., 1981). However, this 
approach has not been used to identify the relationship between genetic variation and 
mechanisms of appetite regulation; Our laboratory has lines of pigs from the same base 
population that have undergone ten generations of divergent selecticm for either fast (F) 
or slow (S) postweaning average daily gain (ADG). Woltmann et al. (1992) reported that 
the F and S lines differed in ADG (0.16 kg/d) and average daily feed intake (ADFI) (0.41 
kg/d) when allowed ad libitum access to feed, but had similar ADG when feed intake was 
standardized. Because these lines originated from a common base population and have 
been maintained in the same environment, the differences in appetite can be attributed to 
selection-induced changes in the frequencies of DNA sequences (gene alleles and gene 
regulatory sequences) that determine this trait. Thus, investigation of the genetic variation 
at the DNA level may help develop new methods to improve the genetic merit of this trait 
( e.g. molecular marker-assisted selection (MSA), Soller et al., 1982; Rothschild et al., 
1990). MSA selection will first require identification of candidate genes or anonymous 
genetic markers associated with traits of interest. A few studies have shown association of 
genes with quantitative trait loci (QTL) in pigs (Rothschild et al., 1990; Jung et al., 1989; 
Clamp et al., 1992; Andersson et al., 1994; Yu et al., 1995). 
The hormone cholecystokinin-8 (CCK-8) has been reported to play a role in 
appetite regulation through its ability to induce satiety in various species including pigs 
(Anika et al., 1981; Della-Fera et al., 1979; Micelli et al., 1983; McLaughlin et al., 1985; 
Denbow et al., 1982). Consequently, a study was conducted to determine the 
physiological and molecular bases for the genetic differences in feed intake between the F 
and S lines of pigs by focusing on CCK-8 as a candidate hormone. The objectives of the 
present study were (1) to determine if plasma concentrations of the satiety hormone 
CCK-8 differed between the lines during feeding; (2) to evaluate the dosage-dependent 
effects of exogenous CCK-8 on feed intake in pigs from F and S; (3) to estimate the 




REVIEW OF LITERATURE 
I. Regulation of Food Intake 
The regulation of food intake is a complex process which involves interactions 
between circulating nutrients, hormones and neurotransmitters (Baile et al., 1983; 
Morley, 1987, 1995; Woods and Gibbs, 1989). Early studies were directed at the potential 
ability of circulating nutrients ( e.g. glucose, free fatty acids) to interact with either 
specific CNS neuronal populations ( e.g. neurons in the hypothalamus) or with peripheral 
afferent neuronal pathways. Gibbs et al. (1973) reported that intraperitoneal injection of 
the intestinal peptide hormone cholecystokinin (CCK) reduced meal size in rats, thus 
beginning the "peptide revolution" in the study of the control of feeding. To date, many 
peptide hormones secreted by the gut and/or brain have been shown to have effect on 
feeding. Some of the candidate satiety peptides include CCK, bomebesin, somatostatin, 
glucagon and calcitonin. Among these peptides, however, the best-characterized satiety 
peptide is CCK, which is released from the duodenum during meals in many species and 
appears to effectively inhibit feeding whether administered peripherally via any of several 
routes or directly into CNS (Morley, 1987; Reidel berger, 1994 ). Another group of 
peptides, opioid peptides have been shown to stimulate food intake at both peripheral and 
central sites (Bechara et al., 1985). Extensive evidence has demonstrated that 
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neuropeptide Y (NPY) increases food intake when administered exogenously (Clark et 
al., 1984; Levine et al., 1984; Stanley et al., 1984; Stanley et al., 1986; Leibowitz, 1990; 
Akabayashi et al., 1994; Stanley et al., 1992) and it is suggested that NPY is a long-term 
hunger signal (Shibasaki et al., 1993; Billinton et al., 1991). Insulin action in the brain 
reduces food intake. The relationship between plasma and CNS insulin levels may change 
in association with appetite and obesity, indicating an important role of insulin in the 
central control of food intake and energy balance (Woods et al., 1976; Woods et al., 
1979; Plata-Salaman et al., 1986; McGowan et al., 1992; Brief et al., 1994). The recent 
cloning and sequencing of the ob gene has suggested that its product, leptin, may regulate 
food intake and body weight (Zhang et al., 1994). A new model has been proposed that 
leptin, insulin and NPY may act as long-term regulators of food intake and body weight 
(Kaiyala et al., 1995; Figlewicz et al., 1996). 
Hypothalamus and Food Intake 
Food intake is regulated mainly by the CNS. The hypothalamus is an area of the 
brain associated with food intake. It receives and integrates internal and external signals, 
resulting in appropriate responses. Electrical stimulation of the lateral hypothalamus area 
(LH) initiates feeding, but electrical or chemical destruction of LH results in aphagia and 
weight loss (Hetherington et al., 1940). Electrical stimulation of the ventromedial 
hypothalamus (VMH) inhibits eating in hungry animals, but ablation of this area 
produces hyperphgia and obesity (Anand et al., 1951 ). Thus, interactions between the two 
areas may control food intake. 
Opioid and Feeding 
4 
Opioid peptides refer to a group of chemicals that produce a morphine-like effect. 
At least 20 opioid peptides from brain, pituitary and adrenal tissue have been isolated and 
characterized. All of them have an amino-terminal Met or Leu-enkephalin sequence, and 
all are derived from one of three precursor molecules, pro-opiomelancortin (POMC), 
proenkephalin or prodynorphin. 
Multiple opioid receptors exist in the brain and have been classified as Mu (µ) 
receptors, which have high affinity for morphine and ~-endorphin; delta (6) receptors, 
which have high affinity for enkephalin; and kappa (K) receptors, which have high 
affinity for dynorphin. The pioneering study of Holtzman (1974) showed that naloxone 
was a highly specific antagonist for Mu opioid receptor and decreased food intake in rats. 
Subsequently, naloxone has been shown to decrease food intake in a variety of species, 
including rats and mice (Holtzman, 1974), sheep (Baile al., 1981; Alavis et al., 1991), 
guinea pigs (Billington et al.,1990), rabbits (Sanger et al., 1981), and cats (Foster et al., 
1980). Among the three types of opioid receptors, K and µ receptors appear to be most 
important in the hyperphagia response (Morley et al., 1983, 1984). This assumption was 
supported by recent findings in rats that µ receptors mediated galanin-induced feeding 
whereas feeding induced by fasting was dependent on a pathway mediated by K receptors 
(Barton et al., 1996). Hence, endogenous opioid peptides play important roles in feeding 
behavior (Morley, 1995). 
NPY and Food Intake 
NPY, which contains 36 amino acids, is a member of the pancreatic polypeptide 
family found both in the peripheral sympathetic neurons and in the brain. Exogenous 
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NPY causes increased food intake when administered into the cerebral ventricular (Clark 
et al., 1984; Levine and Morley, 1984) or directly into the paraventricular nucleus in rats 
and mice (Stanley et al., 1984). Chronic administration ofNPY into the paraventricular 
nucleus resulted in obesity in rats (Stanley et al., 1986). Feed intake was reduced in rats 
when antisense oligonucleotides which inhibit the synthesis of NYP were administrated 
into the paraventicular nucleus (Akabayashi et al., 1994). Also in rats, similar results have 
been observed by the immunoneutralization of NPY (Stanley et al., 1992; Shibasaki et al., 
1993). Repeated administrations ofNPY into the paraventricular nucleus caused a 
persistent increase in food intake and considerably accelerated the body weight gain in 
rats (Morley, 1987; Stanley et al., 1986; Leibowitz, 1990). These results, along with the 
findings that NPY decreases energy expenditure (Billinton et al., 1991 ), led to the 
hypothesis that NPY acts as an anabolic central peptide which is involved in both single-
meal and long-term regulation of energy balance. 
Role of Insulin 
In contrast to the acute, peripheral actions of insulin, which are anabolic and 
calorie-storing, the chronic, CNS-mediated actions of insulin are catabolic. Hatfield et al. 
(1974) found that injection of large dose of insulin into the ventromedial hypothalamus 
reduced feeding in normal and diabetic rats. Intracerebroventricular injection of large 
doses of insulin also decreased food intake in rats (Brief et al., 1994; Woods et al., 1979; 
Plata-Salaman et al., 1986). Bilateral injection of insulin antibodies into the ventromedial 
hypothalamus increased food intake (Strubbe et al., 1977). McGowan et al. (1992) 
reported that the most sensitive sites that decreased food intake from injection of small 
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doses of insulin included portions of the ventromedial hypothalamus nucleus, 
paraventricular nucleus, dorsomedial hypothalamic nucleus and arcuate nucleus. They 
also confirmed that injection of insulin antibodies into the ventromedial hypothalamus 
increased food intake and body weight. There is a general agreement that insulin is not 
synthesized in significant amount in the adult animal brain (Figlewicz et al., 1996). Thus, 
changes of brain insulin concentrations can be considered to reflect changes in plasma 
insulin levels. It was hypothesized that insulin is secreted from the pancreas and enters 
the CNS via insulin receptor-mediated transcytosis across capillary endothelial cells 
which comprise the blood-brain barrier (Woods et al., 1976). 
Insulin receptors are located throughout the CNS, including specific hypothalamic 
nucleus which are thought to be important in the regulation of food intake, body weight 
or energy balance. Therefore, insulin effect on food intake may be due to enhancement of 
the effectiveness of some satiety signals and suppression of the effectiveness of some 
hungry signals. When injected intraventricularly with the dose of insulin which is 
subthreshold for suppression of body, exogenous CCK is more effective in the 
suppression of food intake in rats (Riedy et al., 1995) and in baboons (Figlewicz et al., 
1986, 1995). Moreover, a major target of insulin action in the CNS appears to be the 
hypothalamic neurons that synthesize NPY. NPY synthesis, as assessed by both mRNA 
levels in neuronal cell bodies that originate in the arcuate nucleus and NPY peptide levels 
in the paraventricular nucleus, is elevated in association with negative energy balance and 
insulin deficiency ( e.g., fasting and/or diabetes mellitus; Si pols et al., 1995). Replacement 
of insulin either centrally or peripherally in either of these conditions results in a 
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reduction in food intake and a partial or complete suppression of NPY gene expression to 
levels observed under insulin-replete, or free-feeding conditions (Sipols et al., 1995). 
Additionally, the effectiveness of bilateral paraventricular nucleus injections of NPY to 
stimulate feeding is blunted in rats which receive a chronic subthreshold dose of insulin 
through intravenous transfusion (Sipols et al., 1995). The effects of insulin on NPY 
neurons in the CNS appear to be specific for the hypothalamic population only, inasmuch 
as.neurons in other parts of the CNS are unaffected (Leroy et al., 1996). Recently, the 
expression of the leptin gene was reported to increase after insulin administration in rats 
(Saladin et al., 1995) and in vitro adipose tissue of mice (Leroy et al., 1996). Therefore, 
insulin may be an important regulator· for expression of the leptin gene (Saladin et al., 
1995; Leroy et al., 1996). 
Role of Leptin 
The ob gene, long known to be the site of a mutation associated with genetic 
obesity in mice, was recently cloned and found to be transcribed only in adipocytes 
(Zhang et al., 1994). Its product, leptin, is a polypeptide with 167 amino acids that can 
regulate food intake in mice (Zhang et al., 1994). 
Peripheral treatment of either ob/ob mice or wildtype mice with dietary-induced 
obesity with recombinant leptin reduced food intake, body weight and percentage of body 
fat (Campfield et al., 1995; Halaas et al., 1995; Pelleymount et al., 1995). Intravenous 
injection of recombinant leptin decreased food intake in fasted normal mice (Rentsch et 
al., 1995). These effects appeared to be sustained for as long as leptin was administered 
(Pelleymount et al., 1995). In the studies ofleptin's effect on energy balance, Halaas et al. 
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(1995) and Pelleymount et al. (1995) reported that intraperitoneal infusion of leptin 
normalized the reduced energy expenditure characteristic of ob/ob mice. All these 
findings suggest that the leptin plays an important role in the regulation of food intake 
and is necessary for a normal metabolic profile and for maintenance of normal adiposity 
in rodents. 
Moreover, numerous studies have been conducted to elucidate the relationships of 
leptin with other hormones involved in appetite regulation or/and energy balance 
(Stephens et al., 1995; Saladin et al., 1995; Grunfeld et al., 1996). Stephens et al. (1995) 
reported that leptin receptors were detected in the hypothalamus and infusion of leptin 
into the hypothalamic nucleus decreased hypothalamic levels of NPY in rats. This 
indicates that leptin produced by replete adipose tissue regulates food intake and the 
mechanism is due to the inhibition of NPY synthesis and release. Saladin et al. (1995) 
reported that injection of insulin in fasted rats increased leptin mRNA to the levels of the 
fed controls. So, insulin may regulate leptin gene expression directly in rats independent 
of its glucose-lowering effects, and the increased leptin gene expression after food 
ingestion in rats may act through a direct action of insulin on the adipocyte (Saladin et al., 
1995). In Chinese hamsters, expression of leptin was induced by endotoxin (LPS) and 
cytokines (TNF, IL-1) which are known to regulate adipose tissue metabolism and to 
induce secretion of several hormones involved in appetite regulation ( e.g. CCK, glucagon 
and insulin, etc.) (Grunfeld et al., 1996). 
Cholecystokinin and Its Effect on Satiety 
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The hypothesis that CCK functions as a satiety signal was based on the finding 
that systemic injection of CCK reduced food intake in rats (Gibbs et al., 1973). Since 
then, evidence from studies of both agonists and antagonists of CCK have supported this 
hypothesis in many species (Morley, 1985, 1995). It remains to be determined, however, 
where and how endogenous CCK might act to produce satiety. One popular hypothesis is 
that CCK acts indirectly through control of gastric emptying (Reidelberger, 1994; Figure 
1 ). This hypothesis proposes that chyme entering the small intestine during and after 
ingestion of a meal stimulates secretion of CCK from endocrine cells in the upper 
intestine. Circulating CCK slows gastric emptying, which produces an increased rate of 













Figure 1. Schematic diagram of putative cholecystokinin (CCK) satiety mechanisms based 
primarily on studies of the effects of exogenous CCK on food intake. Solid lines represent 
putative regulatory feedback mechanisms to suppress feeding. (Fmm Reidelberger, 1994) 
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It is generally agreed that heterogeneous forms of CCK exist in plasma and tissue. 
Among these molecular forms, the eight amino acid form of CCK (CCK-8) is thought to 
be the smallest bioactive (Jensen, et al., 1982) and the most biologically potent form of 
CCK causing satiety (Crawley et al., 1994; Reidelberger, 1994). Exogenous CCK-8 
inhibits feed intake in a variety of species (sheep, Della-Fera et al., 1979; rats, Joyner et 
al., 1993; goldfish, Himick et al., 1994; baboons, Figlewicz et al., 1992; chickens, Covasa 
et al., 1994; humans, Rehfeld et al., 1978) including pigs (Anika et al., 1981; Baldwin et 
al., 1992). Specific antagonists for CCK-A receptors (CCKAR) (Ebenezer et al., 1990, 
Baldwin et al., 1992), and specific immunoneutralization of circulating CCK-8 (Pekas et 
al., 1993), has been shown to increase feed intake in pigs. Conversely, CCK agonists 
decrease feed intake in pigs (Parrott, 1993). Thus, CCK is identified as a satiety hormone 
mp1gs. 
II. Biological Characteristics of CCK Peptides and Receptors 
Discovery of CCK peptides 
Ivy and Oldberg (1928) reported that instillation of fat into the dog small intestine 
stimulated the release of a substance that activated gallbladder contraction. The substance 
was termed cholecystokinin (CCK). Harper and Raper (1934) discovered a hormone that 
was released from the porcine duodenal mucosa and stimulated pancreatic enzyme 
secretion; they named the hormone pancreozymin (PZ) for that reason. Mutt and Jorpes 
(1971) isolated a 33-amino-acid polypeptide from extracts of small intestine which 
exhibited the properties ascribed to CCK as well as PZ (Jorpes et al., 1966). What 
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originally was regarded as two distinct hormones was a single hormone. Since the action 
on the gallbladder was first discovered, the acronym CCK is now used instead of PZ or 
CCK-PZ. 
CCK synthesis pathway 
CCK was originally purified from porcine intestine (Jorpes et al., 1966) and sequenced as 
a 33 amino acid peptide (Mutt and Jorpes, 1968, 1971\ Since then, molecular forms 
ranging in size from 5 to 58 amino acids have been identified in extracts of intestine, 
brain, and blood of several species. The 33-amino acid sequence and its 8-amino acid C-
terminal have been identified in pigs, rats, chickens, chinchillas, dogs and humans 
(Eysselein et al., 1984; Fan et al., 1987; Maton et al., 1982; Rehfeld, 1978 ). A 39- amino 
acid sequence was reported in pigs (Mutt, 1980), dogs (Eysselein et al., 1984) and guinea 
pigs (Dockary et al., 1981). A 58-amino acid sequence was reported in-cats, dogs and 
humans (Eberlein et al., 1988). A 47-amino acid sequence was found in frogs and in 
turtles (Johnson et al., 1992). As for forms shorter than CCK-33, CCK-25, CCK-18, 
CCK-8, CCK-7, and CCK-5 were isolated from dog intestine (Reeve et al., 1986), and 
CCK-22 and CCK-8 were identified from rat (Eng et al., 1984) and guinea pig intestines 
(Zhou et al., 1985). All of these molecular forms contain the same five amino acid 
sequence at the C-terminus which is identical to that of another gut hormone, gastrin. 
CCK-like bioactivity is conferred by sulfation of tyrosine at position 7 from the carboxyl 
terminus and all sulfated molecular forms larger than CCK-7 have full biological activity. 
The C-terminal sulfated octapeptide sequence, Asp-Tyr(S03H)-Met-Gly-Try-Met-Asp-
Phe-NH2, known as CCK-8, is relatively conserved across species, and appears to be the 
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minimum sequence for biological activity and the most biologically potent form of CCK 
causing satiety (Crawley et al., 1994; Reidelberger, 1994). 
All molecular forms of CCK are produced by the posttranslational modifications 
of a single gene (Crawley et al., 1994). The gene is about 7 kilobase in size and is 
composed of three exons. The first exon is small and encodes only the 5' untranslated 
portion of the CCK rnRNA. The second exon contains sequences encoding the signal 
peptide and prohormone regions of the peptide, and the third exon encodes the 
biologically important region of the hormone. Transcription of this gene in rats and in 
humans produces a mRNA of approximately 750 bases of which 345 encode the prepro-
CCK (Deschenes et al., 1984; Takahishi et al., 1985). Prepro-CCK consists of 114 amino 
acids in pigs (Gubler et al., 1984) and 115 amino acids in humans (Takahishi et al., 1985) 
and rats (Deschenes et al., 1984). Structure of human prepro-CCK is shown in Figure 2. 
Posttranslational modifications of prepro-CCK include sulfation of the tyrosine, cleavage 
of the C-terminal Gly-Arg-Arg extension, amidation of the C-terminal phenylalanine, 
cleavage of the N-terminal leader sequence, cleavage of the carboxyl side of Arg-74 
(Blanke et al., 1993), and cleavage of CCK-58 and smaller peptides (Turkelson et al., 
1990). The various molecular forms of CCK are generated by trypsin-like cleavage 
(Cantor, 1989). The proposed processing pathway of human prepro-CCK has been 
reported (Eberlein et al., 1992) and is shown in Figure 3. Both the C-terminal sulfation 
and amidation are important for the biological activity (Crawley et al., 1994; Cantor, 
1989). Sulfated CCK is 100 to 300 fold more potent than nonsulfated CCK (Vinayek et 
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Figure 2. Structure of human preprocholecystokinin. The structure is shown of human 
preprocholecystokinin determined by cDNA studies. Basic residues are boldface; double 
basic residues are italic; and predicted single basic residue processing sites are underlined 
Actual processing sites as determined by peptide purification and characterization are 
shown by arrows. Sulfation sites are shown with asterisks. (From Eberlein et al., 1992) 
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Figure 3. Proposed processing pathway of human preprocholecystokinin. Shown at 
the top are five regions of the primary preprocholecystokinin mRNA product of 115 
residues. The signal peptide (Sig. Pep.) is 20 amino acids long. The amino-terminal 
flanking peptide (N-Term. Fl. Pep.) connects the signal peptide to CCK-58. The amidation 
region (Am.Reg.) is a tripeptide (Gly-Arg-Arg), and the carboxyl-terminal flanking peptide 
(C-Term.Fl.Pep.) is a nonapeptide. Post-translational processing is regulated by enzymes 
shown above the arrows. PAM, peptidylglycine a.-amidating monooxygenase. 
Pyrrolidinecarboxylic acid (pQ) is formed by cyclization of the glutamyl at position 1 after 
the action of signal peptidase. (From Eberlein et al., 1992) 
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Enzymes involved in posttranslational processing include a 34,000 dalton 
molecular weight intestinal enzyme which degrades CCK-33 to CCK-12 and CCK-8 
(Turkelson et al., 1990). In plasma, CCK-33 is cleaved to CCK-8 by enterokinase and 
trypsin (Gaisano et al., 1984; Mutt et al., 1981; Straus et al., 1978), and CCK-9 and CCK-
10 are cleaved to CCK-8 by a trypsin-like enzyme(Deschodt-Lanckman, 1982). Sulfated 
CCK-8 may be cleaved into inactive fragments by aminopeptidase (Deschodt-Lanckman, 
1982). 
In the study of CCK peptides in human and rat plasma, half-lives of sulfated 
CCK-8 were 50 and 17 min, respectively, and that of desulfated CCK-8 were shorter, at 
18 min in human and 5 min in rats (Koulisher et al., 1982). 
Localization of CCK production 
1. Distribution of CCK in CNS 
Radioimmunoassay (RIA), immunohistochemistry and in situ hybridization have 
been used to study the distribution of CCK peptides in the CNS. Neurons containing 
CCK are widely distributed throughout the brain except the cerebellum (Beinfeld et al., 
1981). CCK or CCK mRNA is present in a very high concentration in the cerebral cortex 
(Crawley et al., 1994). The distribution of immunoreactive CCK in brain regions of the 
rat was reported by Beinfeld et al. (1981; Table 1). Most of the information regarding the 
localization of CCK in the brain has been obtained from studies of the rat, and similar 
distribution patterns of CCK were also observed in other species such as pig (Rehfeld, 
1978); guinea pig (Larsson et al., 1979); human (Beinfeld et al., 1981; Emson et al., 
1982; Geo la et al., 1981 ); cattle (Braden et al., 1981 ), rhesus monkey (Beinfeld et al., 
1983) and sheep (Dockray et al., 1978). 
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ng CCK-8 equivalents/ 
g net weight 
528 ± 129 
328 ± 73 
274 ± 0.3 
237 ± 68 
232 ± 58 
204 ± 61 
191 ± 36 
164 ± 57 




25 ± 6 
1 ± 0.3 
ng CCK-8 equivalents/ 
brain region 












0.3 ± 0.4 
0.3 ± 0.5 
a Means± SEM, n = 3. Striatum included equdate putamen, globus pallidus, and nucleus 
accumbens. Tissues were removed, frozen and weight before extraction (From Reinfeld et 
al, 1981). 
Rehfeld ( 1978) used RIA in combination with high performance liquid 
chromatography (HPLC) to show that heterogeneous CCK was present in the brain as 
well as in the small intestine of both humans and pigs. To date, CCK-8 has been isolated 
from the brains of a substantial number of mammalian species including, rabbits (Straus 
et al., 1977), pigs (Rehfeld, 1978), sheep (Dockray et al., 1978), and humans (Miller et 
al., 1984). CCK-58 has also been isolated from dog (Eyssenlein et al., 1984) and pig 
brain (Tatemoto et al., 1984). However, neither CCK-33 nor CCK-39 has been isolated 
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from the brain of any species. How the posttranslational processing occurs in the brain is 
still unknown. There may be different cleavage enzymes in the brain. 
2. Peripheral system 
a) Gastrointestinal tract 
High concentrations of CCK are present in the mucosa of the duodenum and 
jejunum in humans, dogs and rats (Soll et al., 1985). CCK-33 or larger forms are found in 
high concentrations in the mucosa in the duodenum and jejunum (Greeley et al., 1984a). 
Use of a C-terminal antiserum for CCK-8, Greeley et al. (1984a) determined that 
concentrations of CCK-33 and larger forms were 5 to 20 times higher than CCK-8 in the 
mucosa of the duodenum and jejunum. CCK-8 has also been detected in the gastric 
atrium, but not in liver, kidney, spleen, or pancreas of the rat, rabbit or dog (Brand et al., 
1981). 
b) Nervous system 
In the aforementioned studies, extracts of the whole tissues were used. 
Investigators have also found CCK in neural and nonendocrine cells of the 
gastrointestinal tract (Larsson et al., 1979). CCK is expressed in a small but significant 
population of neurons in both the myenteric and submucous plexus of the enteric nervous 
system (Schultzberg et al., 1980; Furness et al., 1985). In addition, CCK fibers were 
identified in the mucosa of duodenum and jejunum (Larsson et al., 1979). CCK was also 
found in nerve terminals of pancreatic islets (Rehfeld et al., 1980) and in vagal afferent 
fibers in dogs and cats (Dockray et al., 1981; Rehfeld et al., 1983; Zarbin et al., 1981 ). 
c) Plasma 
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CCK exists in heterogeneous forms in plasma and tissue (Crawley et al., 1994). 
However, the exact molecular nature of CCK in plasma has been much debated because 
of the presence of interfering factors (e.g., gastrin) and differences in the specificity of the 
assays employed. Investigators have pretreated plasma in various ways including 
extraction with acid or ethanol as well as application of resins to decrease the interference 
(Jansen et al., 1983; Go et al., 1980; Liddle et al., 1985; Walson et al., 1982; Cantor and 
Rehfeld, 1987). Although these methods remove interfering compounds, none resulted in 
complete recovery of added CCK. Various values in basal levels of CCK have been 
reported because of the use of antibodies with different specificities, different methods of 
extraction, and different methods and forms of CCK used for iodination (Jansen et al., 
1983; Go et al., 1980; Liddle et al., 1985; Walson et al., 1982; Cantor and Rehfeld, 1987; 
Chang et al., 1983; Kothary et al., 1983; Maton et al., 1982). 
With the use of antibodies specific for CCK-33 and CCK-39, values for CCK-33 
and CCK-39 in unextracted plasma from humans, dogs and pigs were in the range of 16 
to 50 pmol/L (Chang et al., 1983; Jansen et al., 1983; Kothary et al., 1983; Maton et al., 
1982). With the use of similar antibodies, the range of values in plasma pretreated by 
ethanol extraction was 1-4 pmol/liter (Lilja et al., 1982; Lonovics et al., 1981; Gaisano et 
al., 1984). 
In extracted plasma, the use of antibodies against both CCK-8 and CCK-33 or 
CCK-8 alone, resulted in measurement of fasting plasma levels of 1 to 8 pmol/L in rats 
(Maton et al., 1982; Eysselein et al., 1984; Chang et al., 1983; Calam et al., 1982; 
Greeley et al., 1984b ). In humans, the basal concentration was 1 to 3 pmoVL (Rehfeld, 
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1978; Cantor, 1986; Jensen et al., 1983; Liddle et al., 1985; Dockray et al., 1978), and 
similar concentrations have been reported in rats (Liddle et al., 1984) and pigs (Cantor 
and Rehfeld, 1989). 
Reports from different laboratories vary as to the exact molecular patterns of the 
heterogeneity of CCK in plasma. Kothary et al. (1983) reported that human plasma 
contained 10% of CCK peptides larger than CCK-39, 3% of CCK-33 and CCK-39, 11 % 
of CCK peptides with molecular weight between CCK-8 and CCK-33, 58% of CCK-8 
and 18% of CCK-4. Liddle et al. (1985) reported that predominant CCK-33/39, lesser 
amounts ofCCK-22 and CCK-8 and no CCK-58 were in postprandial plasma. Cantor and 
Rehfeld (1987) found a predominance of CCK-33/39 and CCK-8, and moderate to small 
amount of CCK-22 and CCK-58 forms, respectively. Jansen and Lamas (1983) reported 
that 8 to 40% of CCK-58, 44 to 60% of CCK-33 and CCK-39, 15 to 27% of CCK 
peptides greater than CCK-14 but less than CCK-33 were present in human plasma, but 
no CCK-8 was detected. Calam et al. (1982), however, reported CCK-8 to be the 
predominant form and a lesser amount of CCK-33 in human plasma. The molecular 
distribution of CCK in human and pig plasma is almost identical (Liddle et al., 1985; 
Cantor and Rehfeld, 1989), but CCK-22 and CCK-8 have been the only forms detected in 
rat plasma (Liddle et al., 1984). CCK-58 was reported to be the major form of CCK in 
dogs (Eysselein et al., 1987; Sun et al., 1992). These data indicate that various patterns of 
CCK occur in different species. 
CCK receptors---Characterization, distribution and function 
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There are two subtypes of CCK receptors. They are pharmacologically classified 
on the basis of their affinity for the peptide agonists CCK and gastrin, which share the 
same C-terminal pentapeptide amide sequence but differ in sulfation at the sixth (gastrin) 
and seventh (CCK) tyrosyl residues, and by recently developed subtype-specific 
antagonists (Presti et al., 1993). CCK A-receptor (CCKAR) was first characterized on rat 
pancreatic acinar cells (Sankaren et al., 1980), and the second subtype with a different 
pharmacology was discovered in the brain and termed as CCK B-receptor (CCKBR; Innis 
and Synder, 1980). CCKAR is highly selective for sulfated analogues of CCK and the 
antagonist L-364,718 (Lotti et al., 1989), whereas CCKBR has a similar affinity for both 
sulfated and nonsulfated peptide analogues of CCK/gastrin peptides (Saito et al., 1981) 
Table 2. Characteristics of the two subtypes of CCK receptors b 
Nomenclature CC KAR CC KBR 
Potency order CCK-8 >> gastrin, 8 = gastrin, des-CCK-8 
des-CCK-8CCK- (0 to 10 fold) 
(-500 to 1000 fold) CCK-8 > CCK-4 
CCK-8 >>> CCK-4 (10 to 600 fold) 
(-10,000 fold) 
Selective antagonist L-364,718 L-365,260 
G protein coupled Yes Yes 
Signal transduction 
PLC, IP, DAG Yes Yes 
cAMP Yes No 
b CCK, cholecystokinin; CCK-8 and CCK-4, cholecystokinin octapeptide and 
tetrapeptide, respectively; CCKAR and CCKBR, CCK-A and CCK-B receptors, 
respectively. G Protein, guanine nucleotide-binding regulatory protein; PLC, 
phospholipase C; IP, inosito phosphate; DAG, diacyglycerol. (From Wank, 1995) 
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Table 3. Location and function of CCK receptor subtypes c 
CCKAR 
Pancreatic acini 
Enzyme secretion t; growth. 
Gastric mucosa 
Chief cell---pepsinogen t; 
D cell---SMS t· 
' 
Gallbladder and GI smooth muscle 
contraction; motility. 
Select area of CNS and PNS 
Satiety; 







Anxiety, panic attack; Dopamine release .J... 
Gastric mucosa 
Growth; 
Parietal cell---acid t; 
ECL cell---histamine t; 
Chief cell---pepsinogen t; 
Immune cells 
T lymphocytes; monocytes. ? function. 
Neoplastic cells---growth 
ARJ42; Leiomysarcoma; SCLC; 
Gastric carcinoma; Colonic carcinoma. 
c CCK receptors are classified into a major subtypes on the basis of their pharmacology. 
Arrows indicate the change in function mediated by each rec_eptor subtype. SMS, 
somatostatin analogue. CNS and PNS, central and peripheral nervous system, 
respectively; GI, gastrointestinal; ECL, enterochromaffine-like. _ SCLC, small cell lung 
carcinoma (From Wank, 1995) 
and the antagonist L-365,260 (Lotti et al., 1989). Molecular genetics analysis indicates 
that the CCKBR and the gastrin receptor are derived from the same gene and are the same 
protein (Wank et al., 1992). Characteristics of the CCKAR and CCKBR, and their 
locations and functions are summarized in Table 2 and Table 3, respectively. 
Using radioligand and autoradiography, high levels of CCKAR binding in 
peripheral organs, and high levels of CCKBR binding in the CNS have been detected 
(Wank, 1995). Stimulation of CCKAR with physiological concentrations of CCK causes 
pancreatic exocrine enzyme secretion (Sankaran et al., 1980), endocrine islet cell 
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secretion of insulin (i.e., the incretin effect of CCK; Karlsson et al., 1992), secretion of 
pancreatic polypeptide (Liddle et al., 1990), and pancreatic growth (Zucker et al., 1989). 
CCKAR in the stomach mediate secretion of pepsin from gastric chief cells (Gaisano et 
al., 1984) and release of somatostatin from D cells of gastric mucosa resulting in the 
inhibition of acid secretion. Also, CCKAR on smooth muscle cells have been reported to 
cause gallbladder emptying (Bitar et al., 1982). 
CCKAR are located predominantly in the peripheral, however, they are also 
present in nerve fibers in select areas of the CNS and peripheral nervous system (PNS) 
(e.g. vagus nerve) where they mediate the satiety effect of CCK released from the small 
intestine or enteric neurons after a meal (Corp et al., 1993; Ritter et al., 1994; Smith et al., 
1981, 1985; South et al., 1988). CC KAR in the medial posterior nucleus accumbens 
regulate dopamine release (Grawley, 1991) and those in the dorsal horn of the spinal cord 
in primates antagonize opioid analgesia tolerance (Baber et al., 1989). CCKAR on the 
anterior pituitary are suggested to mediate the release of adrenocorticotrophic hormone 
and ~-Endorphin (Kamilaris et al., 1992). CCKAR are also found in several cell lines, 
e.g., the rat pancreatic carcinoma cell line (AR42J) (Logsdon, 1986) and the human 
neuroblastoma cell line (CHP212) (Klueppelberg et al., 1990), leading to the conclusion 
that they may mediate cell growth. 
CCKBR are predominantly found throughout the CNS. CCK acting on CCKBR 
in the anterior nucleus accumbens, unlike CCKAR in the posterior nucleus accumbens, 
has an inhibitory effect on dopamine release (Crawley, 1991 ). This suggests a possible 
role in the pathogenesis of dopaminergic related movement and behavioral disorders in 
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the human (Crawley, 1991). CCKBR are also found to mediate the regulation of anxiety 
by peripheral and central CCK (Harro et al., 1993). CCKBR are present on immune cells 
such as monocytes (Sacerdote et al., 1991) and T lymphocytes (Lignon et al., 1991 ), 
where their functions are still unknown. Like CCKAR, CCKBR are also detected on 
tumors and tumor-derived cell lines such as the AR42J (Logsdon, 1986) and human 
leiomyosarcoma cells (Pearson et al., 1989) where they may stimulate growth. 
III. Animal Models in The Study of Genetic Variation in Appetite 
Food intake is a quantitative trait affected by many genes. In normal animals, each 
of these genes has relatively small effect on phenotype. Genetic variation in appetite may 
be due to the simultaneous segregation of many genes involved in the control of food 
intake and the regulation of energy balance. Genetically-inherited models of obesity in 
rodents have been clearly established to study the genetic nature of the regulation of food 
intake. The identification of the genes involved in the development of obesity in these 
animal models may lead to the elucidation of the underlying basis for quantitative genetic 
variation in appetite and energy balance. 
Yellow obese (AYa) mouse 
Obesity in the AYa model is inherited through a dominant gene (the agouti gene) 
(Bray et al., 1979). Recent studies have determined that the agouti gene is located on 
chromosome 2 in the mouse and on chromosome 20 in the human (Kwon et al., 1994). 
The mouse agouti gene was cloned and found to encode a 131 amino-acid protein 
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(Bultman et al., 1991, 1992; Miller et al., 1993; Michaud et al., 1994; Lu et al., 1994). 
The agouti protein antagonizes the binding of a-melanocyte-stimulating hormone ( a-
MSH) and certain other pro-opio-melanocortin peptides (POMC) to their receptors (Lu et 
al., 1994; Willard et al., 1995). One of the effects of a-MSH is to stimulate food intake 
(Morley, 1987; Shimizu et al., 1989). 
Obesity is associated with a change of pigmentation from black to yellow because 
the genes controlling obesity and the agouti coat colors are so closely linked. To date, 34 
or more alleles at the mouse agouti locus have been identified (Lyon et al., 1990; 
Siracusa, 1994 ). These alleles can be arranged in a phenotypic dominance hierarchy 
(Lyon et al., 1990). A vy is one of the four dominant agouti mutations associated with 
pleiotropic effects (the other three are AY, Aiapy and Aiy). The most prominent effects are 
obesity, hyperinsulinemia and hyperphagia (Yen et al., 1994). Yellow Avy/- mice eat 10 
to 36% more than their non-Avy siblings, depending on genetic strain background (Yen et 
al., 1994). The pituitary of yellow Avy/a mice has a reduced a-MSH: desacetyl-a-MSH 
ratio (Bray et al., 1988). Because desacetylated a-MSH is more potent than a-MSH in 
stimulating food intake (Shimizu et al., 1989), reduced acetylation of a-MSH may play a 
role in A vy -associated hyperphagia. 
Obese (ob/ob) mouse 
Obesity in ob/ob mice is caused by an autosomal recessive mutation (Ingalle et 
al., 1950). The ob/ob mice are obese, hyperphagic, hyperglycemic, hyperinsulinemic, 
insulin resistant and hypoactive (Bray et al., 1979). CCK content in brains of ob/ob mice 
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is lower than their lean (-lob) littermates (Straus and Yalow, 1979). Furthermore, ob/ob 
mice overexpress the neuropeptide Y gene in hypothalamus (Wilding et al., 1993). 
To date, the ob (leptin) gene has been located on chromosome 6 in mice (Zhang et 
al., 1994), on chromosome 7 in human (Green et al., 1995), on chromosome 4 in bovine 
(Stone et al., 1996) and on chromosome 18 in porcine (Sasaki, et al., 1996; 
Neuenschwander et al., 1996). As described in the previous section, studies have revealed 
that leptin plays an important role in the regulation of food intake and energy balance in 
rodents (Halaas et al., 1995; Pelleymount et al., 1995; Rentsch et al., 1995). However, to 
my knowledge, the function of leptin has not been clarified in other species. 
Diabetic (db/db) mouse 
The recessive mutation of the db gene originally arose in the C57BL/KsJ strain of 
mice at the Jackson Laboratories (Coleman, 1978). The db/db mouse is distinguished 
from other obese mouse models by the appearance of ketosis. Like all other obese rodent 
models, the db/db mouse is hyperphagic, hyperinsulinemic and obese (Bray et al., 1979). 
Increased levels of leptin mRNA were reported in adipose tissue of the db/db mouse 
(Trayhum, 1996). Also, leptin suppressed food intake and decreased body weight 
dramatically when administered to normal and ob/ob mice, but not db/db (diabetic) mice 
(Stephens et al., 1995). Thus, the db/db phenotype seems to reflect a defect in the leptin 
action. Recent studies have determined that the db gene encodes the leptin receptor and is 
located on chromosome 4 in the mouse (Tartaglia et al., 1995; Lee et al., 1996). 
Fatty (fa/fa) rat 
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The autosomal recessive mutation (fa) in the rat was first described by Zucker and 
Zucker (1961) and arose from a cross between Sherman and Merck stock M rats. 
Homozygous recessive (fa/fa) rats are obese, hyperphagic, hyperinsulinemic and 
hyperlipemic. Zucker obese rats (fa/fa) are less sensitive to the satiety effects of CCK 
(Moos et al., 1982) and have elevated NPY production in the arcuate nucleus (Beck et al., 
1990; Sanacora et al., 1990). In addition, the level of leptin mRNA in adipose tissue is 
higher infa/fa rats (Trayhum, 1996). The/a locus maps to chromosome 5 in the rat (Chua 
et al., 1996; Iida et al., 1996; Murakami and Shima, 1995) and the normal allele (FA) 
encodes the leptin receptor (Chua et al., 1996; Chen et al., 1996). 
OLETF rat 
Results from a Japanese laboratory described physiological and molecular studies 
performed on an inbred strain of rats, Otsuka Long-Evans Tokushima Fatty (OLETF) 
rats. The OLETF rat was developed in 1992 as a model of human-non-insulin-dependent 
diabetic mellitus from an outbred colony of spontaneously diabetic rats (Kawano et al., 
1992). Male rats develop late-onset hyperglycemia (after 18 wk of age), mild obesity, and 
insulin deficiency ( after 65 wk of age). Elevation of plasma CCK by either exogenous 
CCK administration or endogenous secretion after bile-pancreatic juice diversion failed to 
stimulate pancreatic exocrine secretion in the OLETF rat (Funakoshi et al., 1995). 
Cerebroventricular administration of sulfated CCK-8 did not inhibit daily food intake in 
the OLETF rat (Miyasaka et al., 1994). The incretin effect of CCK, a function mediated 
by CCKAR on islet cells, is also absent in the OLETF rat (Funakoshi et al., 1995) and no 
CCKAR mRNA is detected in either pancreas or hypothalamus (Miyasaka et al., 1994; 
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Funakoshi et al., 1994, 1995). These physiological and molecular studies suggest that the 
OLETF rat may represent a naturally occurring CCKAR gene "knockout" rat and can be 
used as a model to study the physiological function of CCKAR, especially for feeding 
behavior (Wank, 1995). 
IV. Animal Population in the present Study 
1) Establishment of divergent selection lines 
A study was started in 1979 to investigate direct and correlated responses to 
divergent selection for postweaning average daily gain (ADG). In the first year, 
Hampshire boars were purchased in pairs from central test stations in Iowa, Missouri, 
Nebraska and Oklahoma. Boars were evaluated on the index recommended by the 
National Swine Improvement Federation that emphasized increased ADG, decreased 
backfat, and improved feed efficiency as described by Woltmann et al. (1992). In each 
pair, one boar had a high index value (index value ~ 118) and the· other a low index value 
(index value < 90). These boars were mated to a population of Duroc x Yorkshire x 
Landrace x Spotted crossbred gilts from a previous study. In the second year, pairs of 
Duroc boars were purchased on the same index criteria as in the first year. Duroc boars 
were mated with females produced in the first year. The fast growth line (F) was 
generated from pigs sired by high-indexing Duroc boars and out of gilts sired by high-
indexing Hampshire boars. The slow growth line (S) was derived from pigs sired by low-
indexing Duroc boars and out of gilts sired by low-indexing Hampshire boars. The lines 
were then closed and underwent ten generations of selection for either fast (F) or slow (S) 
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ADG from 9 wk of age to 100 kg. Selection lines were replicated in spring- and fall-
farrowing groups. The spring replicate farrowed during mid-March through April and the 
fall replicate farrowed during mid-September through October. Complete replacement of 
boars and gilts resulted in a generation interval of 1 year. 
2) Responses to selection 
Response to selection in F and S through generation four was reported by 
Woltmann et al. (1992). Barrows and gilts from F grew 0.16 kg/day faster than those 
from S. Pigs from Falso ate 0.41 kg/day more feed and had 0.10 cm more backfat at 105 
kg than those from S. After five generations of selection, average daily feed intake for F 
was 23% more than for S (Woltmann et al., 1995). This divergency in feed intake and 
ADG continued through further selection (Clutter et al., 1995). An evaluation of F and S, 
reflecting seven generations of selection is summarized in Tables 4 through 6 (Clutter, 
1992). 
Physiological effects of the divergent selection in F and S were also investigated. 
Norton et al. (1989) measured several plasma characteristics in gilts sampled from F and 
S after generation four. Fasting concentrations of insulin and glucose in peripheral plasma 
were greater in F than in S gilts, but nonesterified free fatty acid levels were greater for S 
gilts than for F. 
Characteristics of GH, IGF-1 and IGF-binding proteins (IGFBP) were studied in 
gilts sampled from the lines after seven generations of selection (Clutter et al., 1995). 
Repeated blood samples were obtained from gilts (-55kg BW) during a period of feed 
deprivation and again during refeeding. None of the characteristics of plasma GH 
concentrations was significantly different between F and S gilts. Plasma IGF-1 
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Table 4. Average daily gain and backfat thickness of F and S Barrows and Gilts 
Sex Line n ADG, kg ADJBF, cm 0 
Barrows F 173 0.91 (0.02i 3.38 (0.01) 
s 129 0.7 (0.02) 2.72 (0.01) 
Gilts F 365 0.88 (0.02) 3.15 (0.01) 
s 218 0.62 (0.02) 2.31 (0.01) 
Mean± S.E. 
0 Average backfat thickness was measured by ultrasonic probe adjusted to 105 kg. 
Table 5. Average daily feed intake and feed conversion ratio of F and S Barrows 






























concentrations were greater in F than in S gilts during feed deprivation and during 
refeeding. A greater IGFBP2 and IGFBP3 activity was detected in S. Therefore, response 
to selection in these lines may have produced some alterations in the IGF-1 pathway. 
V. Genetic Improvement, Molecular Markers and Quantitative Trait 
Loci 
Genetic improvement with the aid of molecular tools 
Genetic improvement as a result of single-trait selection is determined by the 
heritability of the trait, the amount of variation among potential replacements, the genetic 
superiority of the selected replacements, and the time interval required to tum over a 
generation: 
2 R per year = h x SIL 
where 
R is the annual response to selection 
h2 is the heritability of a selection trait 
S is the selection differential 
L is the generation interval 
To enhance annual genetic improvement, breeders need to either increase the 
heritability of a trait ( or the accuracy with which the most genetically superior animals 
are identified), increase the selection differential ( or the measured superiority of selected 
replacements), or decrease the generation interval. 
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Selection of parents is often based on a combination of phenotypic measurements, 
including performance of the individual itself, its ancestors, its siblings and its progeny. 
All of the phenotypic information is analyzed with statistical methodologies to obtain 
breeding values or Expected Progeny Differences (EPDs) for individuals in a population, 
and these EPDs information can be used to make selection decisions. However, it is a 
time-consuming task to obtain these phenotypic data. 
Production traits like growth rate, body composition and litter size are quantitative 
in nature, which by definition means they are affected by many genes each of which has a 
relatively small effect. By selecting the animals with superior performance to be parents 
in the population, the genetic merit of the population is then improved by increasing the 
frequencies of superior gene forms and reducing the frequencies of inferior gene forms. 
However, little is known about the specific genes that affect the various production traits 
and which forms of those genes are desirable. 
Now, due to developments in quantitative and molecular genetics, it is possible to 
study the genetic basis of quantitative traits at the DNA level. These studies include to 
identify, map, and measure the effects of quantitative trait loci (QTLs) or economic trait 
loci (ETLs). QTLs are those loci with relatively minor, quantitative effects on phenotypes 
of production traits, while ETLs are all loci with relatively minor, quantitative or with 
major effects on economically important traits. In order to determine which genes or 
chromosomal regions are important in the control of production traits and to identify 
superior forms of those genes to be used in the selection, a genetic marker map of the 
genome is necessary. When the map is sufficiently saturated with markers, every QTL or 
ETL of interest will reside next to a marker. By monitoring the inheritance of specific 
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marker alleles and the corresponding phenotypic performance of offspring that receive 
them, markers linked to desirable sequences at QTLs or ETLs may be identified. 
Molecular Markers, Mapping and QTL 
There are two major approaches for QTL or ETL studies, the candidate locus 
approach and the genome scanning approach. 
In the candidate locus approach, a restriction fragment length polymorphisms 
(RFLPs) within a gene with known biological functions is used as a genetic marker. 
Genotypies at the candidate locus are are determined for individuals in a segregating 
resource family and association to the phenotype of interest is determined. For example, 
in a study of individual genes affecting murine growth, Winkelman and Hodgetts (1992) 
scored molecular variants at the insulin-like growth factor 2 (IGF-2) and growth hormone 
(GH) loci since these growth factors are known to be important in somatic growth. 
Several genes of major effect on quantitative traits in farm animal species have been 
detected in recent years. In pigs, discoveries have been made which indicate that the 
estrogen receptor locus (ESR) influences litter size (Rothschild et al., 1996) and pituitary 
transcription factor 1 (PITl) is associated with birth weight and backfat (Yu et al., 1996). 
Insulin-like growth factor 1 (IGFl) locus is associated with average daily gain (ADG) 
(Casas-Carrillo et al., 1997). Detection of the associations of these genes with the 
phenotypic performance provides useful scientific tools for the investigation of the 
genetic causes of phenotypic variation. There are several advantages to the candidate 
locus approach: 
1) The results are interpretable in relation to trait physiology; 
2) It provides direct measures of genotypic values. 
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In the genome scanning approach, genotypes are measured at a large number of 
marker loci including candidate gene markers and anonymous markers. The anonymous 
markers are usually in nonfunctional sequences of DNA with unique sequence variation, 
such as microsatellites---DNA sequences made up of tandem repeats and alleles based on 
variable number of repeats (e.g. (CA)n repeats). Amplified microsatellites may be scored 
by agarose or polyacrylamide gel electrophoresis if alleles differ in size (Figure 4). 
Ideally, marker loci spaced approximately 5 to 10 centiMorgans throughout the genome 
are evaluated. With such a high density of marker loci, it is likely that alleles at marker 
loci will be in linkage disequilibrium with QTL alleles resulting in a correlation between 
quantitative trait values and marker genotypes. The advantages of this approach are: 
1) It surveys the entire genome; 
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Figure 5. An example of Fl individual heterozygous for both a DNA marker (with forms M and m) and 
linked QTL locus of interest (with forms Q and q). Genotypes of the marker, and along with them 
genotypes of the linked QTL, segregate in production of the F2. Comparing performance for production 
traits of F2 individuals that receive the different marker genotypes determines the value of QTL linked to 
segregating marker. This example depicts only the pair of chromosomes on which the marker and the QTL 
reside and assumes they are linked tightl)'. enough that there is no crossing over between them. 
Theoretically, studies to locate QTLs or ETLs that affect important traits are 
straightforward. By following the inheritance of alleles of markers throughout the 
genome, and determining the associations of those marker alleles with trait(s) of 
performance, regions of the genome harboring QTLs (ETLs) can be identified. If enough 
evenly spaced markers are used, wherever a QTL resides it will be linked to one of the 
markers. The most effective design is one in which segregating marker alleles are studied 
in an F2 resource family produced by crossing very divergent grandparent stock (e.g. 
wild boar x domestic female). 
A simple example involving a single marker and linked QTL is shown in Figure 
5. The cross of divergent lines should result in an Fl that is heterozygous for the marker 
and QTL alleles. The expectation for the F2 is the 1 : 2 : 1 ratio for three possible 
genotypes at each locus. By comparing average performance of the marker · genotype 
groups for traits of interest ( e.g. growth rate, fat deposition, food intake), a linked QTL 
can be detected. 
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In pigs, this genomic scan approach with microsatellite markers has been used to 
identify chromosomal regions or "hot spots" controlling fatness (Andersson et al., 1994; 
Rothschild et al., 1996), meat quality (Le Roy et al., 1990), growth (Andersson et al., 
1994; Casas-Carrillo et al., 1997b) and ovulation rate (Wilkie et al., 1996; Rathje et al., 
1997). 
Comparative Mapping 
During evolution a dynamic process of chromosomal rearrangements occurs. 
DNA segments are inserted or deleted, chromosomes are translocated or split, and 
genomes are polyploidized. Related species share many features of genomic organization 
and chromosomal structure as seen directly from their karotypes (Nash et al., 1982; 
Sawyer et al., 1986; 0 'Brien et al., 1988; Levan et al., 1991 ). In comparative mapping, 
the genomic localization of two or more loci is compared between species (Nadeau, 1989; 
0 'Brain et al., 1991 ). If the loci are linked or syntenic in more than one species, a 
conserved chromosomal segment is present. These conserved segments are of particular 
importance for gene mapping in farm animals. Whenever a locus is localized to a 
particular conserved chromosomal region, the map can be compared with those of human 
and mice which are much more dense, to find potential candidate genes. By using this 
comparative mapping approach, positional candidates for the RN gene for meat quality 
has been identified in pigs (Milan et al., 1995). OTFl has been located on porcine 
chromosome 4 within a large syntenic group conserved on HSA 1 (Tuggle et al., 1995). 
Thus, the positional candidates for a QTL or ETL in this syntenic region detected on 
HSA 1 will probably be mapped to SSC 4. 
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Marker-Assisted Selection 
In animal industries, the ultimate purpose of gene mapping is to apply the derived 
information in breeding programs. This can be carried out by selection on favorable 
QTLs via selection on linked markers, i.e. marker-assisted selection (MAS) (Soller et al., 
1982, 1990; Rothschild et al., 1990). Better understanding of gene action will also aid in 
building models of phenotypic variation, permitting breeding values to be more 
accurately estimated (Weller, 1996).Although considerable genetic enhancement in some 
performance traits has been achieved with traditional methods (Buchanan et al., 1993), 
more genetic improvement may be obtained by application of MSA (Soller, 1994; 
Weller, 1996). 
MAS has potential to increase genetic response to single trait selection in three 
ways: 1) increase the accuracy for predicting superior candidates; 2) increase the selection 
intensity by considering more young animals as potential parent candidates, as many as 
young animals can be first selected based on genetic markers, and then selected groups of 
parents progeny-tested; 3) decrease the generation interval by elimination of the progeny 
test. Moreover, MAS will be particularly useful for the improvement of traits which are 
sex limited such as milk production by analyzing the DNA information from males, traits 
which are expensive to measure such as feed intake, or traits which can only be measured 
after animals are slaughtered such as body composition (Buchanan et al., 1993). 
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CHAPTER III 
PLASMA CHOLECYSTOKININ-8 DURING FEEDING IN PIGS WITH 
DIVERGENT GENETIC POTENTIAL FOR FEED INTAKE AND GROWTH 
Abstract 
Plasma concentrations of cholecystokinin-8 (CCK-8) in response to feeding were 
studied in lines of pigs with divergent genetic potential for feed intake and growth. 
Differences in feed intake between the lines resulted from ten generations of divergent 
selection for either fast (line F) or slow (line S) growth when both lines were fed ad 
libitum. Two experiments were conducted to test the hypothesis that the lower feed intake 
in S than in F may be due in part to greater plasma concentrations of the satiety hormone 
CCK-8 in S pigs both in the fasted and fed state. In experiment 1, F (n=23) and S (n=19) 
barrows were fed maintenance to attain zero growth at 90 kg body weight and were used 
to determine plasma CCK-8 concentrations in response to ad libitum feed consumption 
independent of differences in growth rate. Blood samples were collected via jugular 
catheter in overnight fasted pigs at 30, 15, and 1 minute before feeding (0800 hr) and at 
10, 20, 30, 60, 90 and 120 minutes after feedings. As expected, barrows from Fate more 
than those from S when allowed ad libitum access to feed (P<0.05). Averaged across 
sampling times, mean concentrations of CCK-8 tended to be greater (P = 0.07) in S (7.63 
pg/ml) than in F (5.76 pg/ml). In experiment 2, plasma CCK-8 concentrations were 
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measured for pairs (F, S; n = 9) of the same barrows in experiment 1 when the intake of 
each pair was standardized to that of the S pig during experiment 1. Blood samples were 
collected as in experiment I. Averaged across times, the difference between CCK-8 
concentrations of S (13.28 pg/ml) and F (9.05 pg/ml) barrows was not significant (P = 
0.18). A line x time interaction was not detected in either experiment. Overall, these 
results indicate a tendency for greater concentration of CCK-8 in S than in F barrows and 
suggest that CCK-8 may play a role in genetic differences between the lines for feed 
intake. 
Introduction 
Feed intake is one of the major factors that determine profitability in the swine 
industry. A better understanding of the genetic basis of appetite may lead to the 
development of more effective selection methods for feed efficiency. Although the 
general physiological processes that result in hunger and satiety have been the focus of 
extensive research (Morley, 1995; Kaiyala et al., 1995; Figlewicz et al., 1996), the 
molecular nature that contributes to genetic variation in appetite remains largely 
unknown. Genetic variation in appetite originates from differences in genes that encode 
the peptides/proteins involved in the feeding control pathways. Investigation of 
populations that differ only in their genetic propensity to eat may lead to identification of 
the relevant physiological pathways that control appetite, and aid in the search for the 
specific genes involved. 
39 
Divergently selected lines of pigs have been studied to understand genetic 
variation in obesity (Wangsness et al., 1981); However, this approach has not been used 
to identify a relationship between genetic variation and mechanisms of appetite 
regulation. Our laboratory has two lines of pigs that have been undergone ten generations 
of divergent selection for either fast or slow postweaning average daily gain (ADG). 
Woltmann et al. (1992) reported that after four generations, barrows from the lines 
differed in gain (0.16 kg/d difference) and feed intake (0.41 kg/d difference) when 
allowed ad libitum access to feed, but had similar gains when feed intake was 
standardized. They concluded that most of the difference in gain was expressed through a 
correlated genetic response in feed intake. Subsequent evaluations of the lines through 
seven generations of selection revealed that gain and feed intake have continued to 
diverge between the lines (Woltmann et al., 1995; Clutter et al., 1995). 
Consequently, a study was conducted to determine the physiological basis for the 
observed genetic differences in feed intake between the lines. The peptide hormone 
cholecystokinin (CCK) has been reported act as a satiety signal in several species 
including pigs (Anika, 1981; Della-Fera et al., 1979; Micelli et al., 1983; McLaughlin et 
al., 1985; Denbow et al., 1982; Morley, 1985, 1995; Silver et al., 1990; Reidelberger, 
1994). The objective of the present investigation was to determine if plasma 
concentrations of an eight amino-acid molecular form of the putative hormone CCK 
(CCK-8) differed between the lines during feeding. The hypothesis was that the S line 
pigs have less appetite and relatively greater circulating concentrations of CCK-8. 
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Materials and Methods 
Selection Lines and Sampling of Lines 
A study was started in 1979 to investigate direct and correlated response to 
divergent selection for ADG. Detailed descriptions of the base population, animal care 
and selection procedures have been reported previously (Woltmann et al., 1992, 1995; 
Clutter et al., 1995). In the first year, Hampshire boars were purchased in pairs from 
central test stations in Iowa, Missouri, Nebraska and Oklahoma. Boars were evaluated on 
the index recommended by the National Swine Improvement Federation that emphasized 
increased ADG, decreased BF, and improved feed efficiency as described by Woltmann 
et al. (1992). In each pair, one boar had a high index value (index value~ 118) and the 
other a low index value (index value < 90). These boars were mated to a population of 
Duroc x Yorkshire x Landrace x Spotted crossbred gilts from a previous study 
(Woltmann et al., 1992). In the second year, pairs of Duroc boars were purchased by the 
same criteria. Duroc boars were mated with females produced in the first year. Line F was 
generated from pigs sired by high-indexing Duroc boars and out of gilts sired by high-
indexing Hampshire boars. Line S was derived from pigs sired by low-indexing Duroc 
boars and out of gilts sired by low-indexing Hampshire boars. The lines were then closed 
and have undergone ten generations of selection for either fast (F) or slow (S) ADG from 
9 wk of age to 100 kg. The selection lines were replicated in spring- and fall-farrowing 
groups. The spring replicate farrowed during mid-March through April, and the fall 
replicate farrowed during mid-September through October. Complete replacement of 
boars and gilts resulted in a generation interval of 1 year. Selection was relaxed after 10 
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generations. Animals for the present experiments were sampled from F and S litters in the 
final set of progeny from selected parents ( spring 1993 ), and the first two consecutive sets 
under relaxed selection (fall 1993 and spring 1994). 
Barrows were chosen for the present study so that potential variation due to sexual 
activity would be avoided and because the most extensive data previously collected in the 
lines for feed intake were from barrows (Woltmann et aL, 1992). Each barrow was 
sampled from a different litter. The litter began postweaning test at 8 weeks of age 
according to the routine procedures implemented in the reference population. When a 
litter reached the approximate average weight of 75 kg, the barrow closest to the average 
weight was chosen so that the candidate barrow from each litter weighed approximately 
90 kg at data collection. The candidate barrows were penned in groups of 4 to 6 in a room 
before they were brought into the experimental rooms. 
Experimental Procedures 
Barrows chosen for the experiments were housed individually in pens (1.8 m2) in 
rooms with an average temperature of 23 ± 3 °c and subject to a 12 hr light: 12 hr dark 
cycle. During an initial acclimation period, barrows were allowed ad libitum access to 
feed (Table 1) except for removal of feed and feed troughs between 2000 hr and 0800 hr 
each day. After this period of acclimation, barrows were fed amounts intended to be 
sufficient only for maintenance of body weight (zero growth) for a minimum of 14 d 
before the start of experiment 1. This was done so that plasma CCK-8 in response to feed 
intake could be compared in F and S barrows without confounding due to differences in 
growth rate. During feeding for zero growth, barrows received approximately 8.5 g 
feed/kg body weight at 0800 hr and 1800 hr daily. The average growth rate of barrows 
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Table 1. COMPOSITION OF DIET USED IN THE STUDY 
Ingredient 
Com 





a As-fed basis 









during the week before experiment 1 was 0.09 kg/d, and did not differ between the F and 
S groups. Thus, the difference in growth rate between barrows from F and S was 
successfully removed for the present experiments. Polyvinyl catheters were inserted into 
the jugular vein of anesthetized barrows 48 hr before experiment 1 began. Catheters were 
tunneled subcutaneously and exteriorized on the dorsal midpoint of the neck. The distal 
end of the exteriorized catheter was fitted with a luer stub adapter, capped and placed in a 
protective packet that was glued to the skin. Catheter length allowed blood sampling from 
outside the pen and thus prevented interference in normal feeding behavior during the 
experiments. Feeding for zero growth was continued during the 48 hr before experiment 
1. Blood collected during feeding was discarded, in order to acclimate barrows to the 
experimental conditions. 
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In experiment 1, barrows sampled from F (n=23) and S (n=19) were used to 
determine the plasma CCK-8 in response to unrestricted feed intake. On the morning of 
the experiment, blood samples (10 ml) were collected into heparinized syringes at 30, 15, 
and 1 min before and 10, 20, 30, 60, 90 and 120 min after introduction of feed and the 
beginning of feeding at 0800 hr. Blood was transferred immediately into tubes held in an 
ice-water bath. 
To measure individual feed intakes, feed (2.0 kg) was weighed to the nearest 1.0 g 
and placed in each of six feed troughs 1 hr before the beginning of the experiment. The 
first trough containing feed was placed in the pen at time O and troughs were removed 
and replaced with a fresh trough of feed at 10, 20, 30, 60, and 90 min. Feed intakes were 
determined as the difference in weight of feed in each trough before and after its 
placement in the pen. Feed intakes were measured within 1 min of blood sample 
collections. 
Experiment 2 was conducted 48 hr after experiment 1. Feeding for zero growth 
was maintained during the 48 hr between experiments 1 and 2. Experiment 2 determined 
the plasma CCK-8 response to feed intake when intakes were equally matched in pair-fed 
F and S barrows. Barrows from F and S were paired randomly and each barrow within a 
pair was allocated an amount of feed equal to the ad libitum intake of the S barrow in that 
pair as measured in experiment 1. Blood samples were collected and feed intakes 
determined as described for experiment 1. A total of 9 pairs of barrows were evaluated in 
experiment 2. 
Radioimmunoassay Protocol and Validation 
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Plasma Extraction: For each sample, 0.7 ml of plasma was extracted with 1.4 ml of 
100% ethanol (Aaper Alcohol and Chemical Co., Shelbyville, KY). Samples were placed 
at room temperature for 30 min after vigorous vortexing for 10 sec. The mixture was 
centrifuged for 30 min (1,500 x g) at 4 °C. The supernatant was transferred into a clean 
12 x 75 mm polypropylene tube and then evaporated in Speed Vac Concentrator (SVC-
1 OOH, Savant Instruments Inc., Farmingdale, NY) at room temperature. The dried 
extracts (unreconstituted) were stored at -20 °C until assayed. 
Radioimmunoassay Procedure: Dried samples were reconstituted to original volume 
with assay buffer (pH 8.5) containing 20 mmol/1 Barbital, 0.05% sodium azide, 0.11 % 
gelatin (all reagents from Sigma Chemical, St. Louis, MO) at least one hour before use. 
Cholecystokinin octapeptide (CCK-8; [Tyr(S03H)27]-Cholecystokinin Fragment 26-33 
Amide, Sigma Chemical, St. Louis, MO) was dissolved in distilled water and diluted with 
assay buffer to produce CCK-8 standards. Reconstituted plasma extract (200 µl) or CCK-
8 standards ( 0, 1, 5, 10, 20, 40, 80, and 120 pg/ml) were added to 12 x 75 mm 
polypropylene assay tubes. Rabbit antiserum (NO. 92128; kindly provided by Dr. J.F. 
Rehfeld, University Hospital, Copenhagen, Denmark) specific for tyrosine 0-sulfated and 
phenylalanine a-amidated CCK-peptides was added ( 200 µl) to all tubes except Total 
Counts and NSB in an initial dilution 1 : 12,500 (a final solution of 1: 50,000), resulting 
in an initial binding of labeled hormone of approximately 34%. Assay buffer (200 µl) was 
added to NSB tubes, and then 300 µl of assay buffer to all tubes except Total Counts. 
Tubes were incubated 24 to 36 hours at 4 °C. One-hundred µl of [125I]-CCK-8 
(Amersham Corporation, Arlington Hts, IL) containing 3000-5000 cpm in assay buffer 
was added to all tubes. Tubes were incubated overnight at 4 °C. One milliliter of cold 
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charcoal/dextran (0.75% dextran, 3.00% charcoal, Sigma Chemical, St. Louis, MO) was 
added to all tubes except Total Counts to separate antibody-bound and free [ 125I]-CCK-
8. Supernatant was aspirated after centrifuging at 1,500 x g for 10 min at 4 °C. Charcoal-
precipitate was counted in an automatic gamma-counter (Micromedic systems, Inc., 
Horsham, PA) and concentrations of CCK-8 in standards and unknown samples were 
calculated by an iterative least-squares regression on percentage binding. 
Validation of CCK-8 Radioimmunoassay: The sensitivity of the assay, defined as the 
smallest amount of CCK-8 which could be differentiated from zero hormone 
concentration with 95% confidence, was 1.4 pg/ml. Accuracy, defined as the extent to 
which measurements of CCK-8 agreed with the exact amount present in a sample, was 
evaluated by adding known amounts of purified synthetic CCK-8 to plasma. When 
known amounts of synthetic CCK-8 were added to pig plasma samples (n=6) before 
extraction, a correlation coefficient (r) of 0.99 was associated with the recovery curve 
(Figure 1). Essentially 100% of the added CCK-8 was recovered by the assay after 
subtraction of the endogenous hormone. Intra-assay precision was determined by 
calculating the coefficient of variation (CV) of 3 pools of pig plasma containing low 
(L.P.), medium (M.P), and high (H.P.) concentration of CCK-8 when each was run seven 
times in one assay (Table 2). Inter-assay precision was determined by calculating the CV 
of 3 pools of pig plasma (L.P., M.P., and H.P.) estimated in 10 separate assays (Table 2). 
The inhibition curves produced by the standard solution of CCK-8 and serial dilutions of 
pig plasma pools are shown in Figure 2. Parallel inhibition curves demonstrated an 
unique combination of antibody and antigen and indicated that the same substance in 
standard solutions and plasma was being measured. 
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Statistical Analyses: 
Methods of least-squares analyses used for data from both experiments 1 and 2 
were as follows. Plasma concentrations of CCK-8 at each of the times relative to 
introduction of feed (-30, -15, -1, 10, 20, 30, 60, 90 and 120 min), as well as cumulative 
feed intake at 10, 20, 30, 60, 90 and 120 min after introduction of feed, were analyzed 
with a model that included the effects of farrowing group (spring 1993, fall 1993, or 
spring 1994), line, the farrowing group x line interaction, animal within farrowing group 
x line, time and all interactions of time with line and farrowing group. Effects of 
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Figure 1. Recovery ofCCK-8 when known amounts of synthetic CCK-8 were added to 
pig plasma samples before samples were extracted (see methods) (n=6). 
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Table 2. PRECISION IN THE CCK-8 RADIOIMMUNOASSA Y 
Precision Pool N 
Intra-assay L.P. 7 
M.P. 7 
H.P. 7 
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Figure 2. Paralfolism in the CCK-8 radioimmunoassay. 
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Figure 3. Cumulative feed intake of barrows and plasma concentrations of CCK-8 in 
barrows from the F and S lines during experiment 1. Barrows were at zero growth, fasted 
overnight and were allowed ad libitum access to feed for 2 hours. Concentrations of CCK-
8 at time O were calculated using the average of 3 observations in each pig. 
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times, concentrations of CCK-8 tended to be greater (P = 0.07) in S barrows (7.63 pg/ml) 
than in F barrows (5.76 pg/ml). A time x line interaction was not detected. 
Results of the analyses of basal CCK-8, response in CCK-8 and total CCK-8 are 
presented in Table 3. Basal CCK-8 tended (P = 0.09) to be greater in S than in F. 
However, neither response in CCK-8 nor total CCK-8 differed between the lines. 
Experiment 2. Mean values for cumulative feed intake in experiment 2 are plotted in 
Figure 4. Cumulative feed intakes did not differ significantly between F and S barrows at 
any of the measurement times. Thus, the objective to constrain F and S barrows to an 
equally matched feed intake was achieved. 
Table 3. LEAST-SQUARES MEANS FOR BASAL CCK-8, RESPONSE IN CCK-8 
AND TOTAL CCK-8 CALCULATED FROM THE AREA UNDER EACH 
CURVE a. 
CCK-8 (muml · min} 
Basal Response Total 
Experiment 1 b 
189.13 ± 35.87d F 894.93 ± 126.07 1084.11 ± 149.50 
s 514.29 ± 181.16 796.92 ± 207.34 1311.22 ± 195.87 
Experiment 2c 
F 551.47 ± 158.07 877.34 ± 173.14 1428.81 ± 255.29 
s 726.93 ± 102.23 1361.39 ± 371.7 2088.32 ± 414.23 
a Trapezoid method. 
b Barrows had ad libitum access to feed after overnight feed deprivation. 
cBarrows pair-fed (F, S) amounts equal to the ad libitum intake in experiment 1 of the S 
barrow in the pair. 
ct Least-square mean± SE. 
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Figure 4. Cumulative feed intake of barrows and plasma concentrations of CCK-8 in 
barrows from the F and S lines during experiment 2. Barrows were at zero growth, fasted 
overnight and F pigs were pair-fed amounts equal to the previous ad libitum intake of the 
S barrow in each pair. Concentrations of CCK-8 at time O were calculated using the 
average of 3 observations in each pig. 
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Least-squares means from the analysis of individual CCK-8 concentrations are 
also plotted in Figure 4. As in experiment 1, concentrations of CCK-8 in both lines 
increased (P < 0.01) after feeding began. Averaged across time, the difference between 
CCK-8 concentrations of S (13.28 pg/ml) and F (9.05 pg/ml) barrows was not significant 
(P = 0.18). A time x line interaction was not observed. 
Each of the mean values for area under the CCK-8 response curve was 
numerically greater for S than for F barrows (Table 3), but no significant difference was 
detected. 
Discussion 
The reports of the selection lines from different generations revealed a continued 
divergence in daily feed intake and ADO between F and S lines (Woltmann et al., 1992, 
1995; Clutter et al., 1995). Barrows from F and Shad similar ADO when feed intake was 
standardized , leading to the conclusion that most of the difference in ADO was exhibited 
through a correlated genetic response in feed intake (Woltmann et al., 1992). Those 
results from the selection lines were in agreement with reports of direct and correlated 
responses to selection for growth in other populations of pigs (Baird et al., 1952; Fine et 
al., 1953; Kuhlers et al., 1992). In other words, the selection for ADO has targeted DNA 
sequences which encode proteins involving the feeding control pathways. 
The regulation of feed intake involves many physiological factors (Morley, 1995; 
Kaiyala et al., 1995; Figlewicz et al., 1996) which, therefore, are candidate sources of 
genetic variation in feed intake. Many peptide hormones have been shown to have effect 
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on feeding (for example. CCK, glucagon, bombesin, leptin, insulin, and NPY). Among 
these peptides, however, one of the best-characterized satiety peptides is CCK (Morley, 
1995). The hypothesis that CCK functions as a satiety signal was initially based on the 
finding that systemic injection of CCK reduced food intake in rats (Gibbs et al., 1973). 
Since then, evidence from studies of both agonists and antagonists has supported this 
hypothesis in many species including pigs (Morley, 1987, 1995; Crawley et al., 1994; 
Reidelberger, 1994). 
CCK is encoded by a single gene (Deschenes et al., 1985) and synthesized via the 
preprohormone pathway. PreproCCK consists of 114 amino acids in pigs (Gubler et al., 
1984) and 115 amino acids in man (Takahishi et al., 1985) and rats (Deschenes et al., 
1984). Different molecular forms of CCK containing 58, 39, 33, 22, 12, 8, or 4 amino 
acids have been identified in tissues arid blood (Cantor,1989; Crawley et al., 1994). In 
pigs, Cantor and Rehfeld (1989) observed that CCK-22-like immunoreactivity accounted 
for 42% of all CCK immunoreactivity in peripheral plasma after intraduodenal infusion 
of HCI, but also reported lesser and equal amounts (24%, respectively) of CCK-33- and 
CCK-8-like forms. Exogenous CCK-8 inhibits feed intake in a variety of species (Della-
Fera et al., 1979; Joyner et al., 1993; Covasa et al., 1994) including pigs (Anika et al., 
1981; Baldwin et al., 1982). Agonists for CCK-A receptors decreased feed intake in pigs 
(Parrott, 1992). Specific antagonists for CCK-A receptors (Ebenezer et al., 1990; Baldwin 
et al., 1992, 1994), and specific immunoneutralization of circulating CCK-8 (Pekas et al., 
1993), have been shown to increase feed intake in pigs. Thus, CCK has been established 
as a satiety hormone in the pig and CCK-8 was chosen as the focus of the present 
experiments. 
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In both experiments 1 and 2, the general patterns of CCK-8 concentrations in 
response to feeding were similar to those reported for humans (Cantor, 1989) and pigs 
(Cantor et al., 1989) in which the assays detecting bioactive forms of CCK were used. 
Cantor (1989), in summarizing reports of CCK in human plasma, concluded that basal 
concentrations of CCK-8 averaged 1 to 2 pM/L ( or 1.1 pg/ml to 2.3 pg/ml) and increased 
from 6 to 8 pM/L (or 6.8 pg/ml to 9.1 pg/ml) after a meal. Cantor and Rehfeld (1989) 
reported basal concentrations of CCK-8 approximately 1 pM/L (or 1.1 pg/ml) in the pig 
that increased to 12.3 pM/L (or 14.1 pg/ml) by 10 min after intraduodenal infusion of 
HCI. 
In experiment 1, CCK-8 concentrations increased following the introduction of 
feed, and seemed to reach a plateau after 30 min in S and after 90 min in F (Figure 3). 
Thus, the tendency for a greater concentration of CCK-8 in S than in F prior to feeding 
was maintained through the first hour after the introduction of feed. The slightly 
contrasting CCK-8 patterns in Sand Fat the end of the experimental period are consistent 
with the continued feed consumption of F barrows from 60 to 90 min after the 
introduction of feed. 
In experiment 2, numeric differences between CCK-8 concentrations of S and F 
barrows were greater than in experiment 1, but can only be considered significant with 15 
to 20% probability of a Type I error. Comparison of the CCK-8 patterns (Figure 4) 
suggests that following the introduction of feed, concentration of CCK-8 tended to 
increase at a greater rate during the first 10 min of feeding in S than in F, after which the 
patterns were very similar for the two lines. The similarity of CCK-8 patterns between S 
and F during the latter part of the experimental period is consistent with the pair-feeding 
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design of experiment 2 and, on the average, the limitation of feed intake by F barrows 
relative to experiment 1. 
Taken together, these results indicate a tendency for greater plasma concentrations 
of CCK-8 in S than in F barrows and support the hypothesis that selection has changed 
feed intake, in part, by altering circulating CCK concentrations. Although the assay 
accurately measured concentrations of CCK-8, adequate statistical power for comparisons 
of this type is generally difficult to achieve due to inherent genetic variation among 
individuals within a selection line. Thus, detection of differences between the lines when 
allowed a standard feed intake (experiment 2) was probably inhibited by the relative low 
power associated with observations on only 18 total pigs. 
The assay procedures implemented here were specific for CCK-8. Although the 
importance of CCK-8 as a satiety signal in the pig has been implied through infusion 
studies (Anika et al., 1981; Baldwin et al., 1982) and the specific immunoneutralization 
of CCK-8 (Pekas et al., 1993), the relative effects of bioactive forms of CCK on feeding 
behavior remains to be determined. The . effect of selection on relative changes of 
molecular forms of CCK in the present experiments can only be determined by additional 
work to separate peptide fractions (HPLC/RIA). In addition, experiments to determine the 
effects of CCK infusion, CCK receptor antagonists and CCK immunoneutralization on 
feed intake in F and S may provide a more complete picture of the role of CCK action in 
genetic differences between the lines. 
Reports of physiological differences between selection lines are relative rare 
(Goddard et al., 1988; McKnight et al., 1989; Arbona et al., 1992; Hastings et al., 1993), 
especially in large-animal species (Arbona et al., 1988; Norton et al., 1989). To our 
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knowledge, studies of CCK in different genetic strains have been limited to ob/ob mice 
(Straus et al., 1979) and Zucker obese rats (McLaughlin et al., 1985; Moos et al., 1982). 
In each case the inheritance of obesity is due to a single gene mutation. Straus and Yalow 
(1979) reported that the CCK content in brains of ob/ob mice was lower than in the brains 
of their OBI- (lean) littermates. Zucker obese rats expressed greater hypothalamic 
concentrations of CCK during the feeding period, but also consumed more feed than 
controls (McLaughlin et al, 1985). Moos et al. (1982) reported that Zucker obese rats 
expressed less sensitivity to satiety effects of CCK than their control littermates. 
Characteristics of CCK action associated with quantitative genetic differences between 
selected lines of animals have not been reported. 
Direct and correlated responses to selection are due to changes in the frequencies 
of gene forms (alleles) affecting each of the measured traits (Falconer, 1989). Although 
differences between divergent lines may be due in part to founder effects in the 
establishment of the lines or random changes in gene frequencies due to finite population 
size (Falconer, 1989), the primary factor affecting gene frequencies in F and S was 
selected for ADG. Therefore, phenotypic and physiological differences between the lines 
are likely due to differences in the frequencies of alleles targeted by selection. Because of 
the complex and quantitative nature of these traits, selection for ADG, and indirectly for 
feed intake, has no doubt targeted the alleles of many genes. 
A previous study of F and S (Clutter et al., 1995) revealed greater plasma IGF-1 
and lesser IGF binding proteins in F than in S, a relationship consistent with the relative 
growth rates of the lines. As those authors discussed, the results indicated the IGF 
pathway was an important mechanism of response to selection, but th,e degree to which 
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selection targeted the IGF and IGF binding protein genes versus other genes that affect 
growth through IGF was not discernible. In addition, because Sand F pigs were measured 
during full expression of their growth potential, the physiological differences observed 
were confounded by the differences in growth rate. 
The design of experiment 1 and 2 of the present study included the condition of 
zero growth to avoid the confounding influence of different growth rates between the 
lines, and experiment 2 was designed to remove confounding due to differences in feed 
intake. However, as discussed by Clutter et al. (1995), these physiological evaluations of 
selection lines only provide a picture of the genetic differences at the protein level. If, in 
fact, concentrations of CCK-8 are different in F and S, it is impossible to determine from 
these comparisons between the lines if selection has acted on the CCK gene directly, on 
genes that code for enzymes involved in the posttranslational modifications of the 
preproCCK, or other genes that result in altered CCK concentrations. 
The availability of markers in anonymous DNA and functional genes from 
throughout the porcine genome (Archibald et al., 1995; Rohrer et al., 1995), including a 
marker for the CCK gene (Clutter et al., 1996), provides the opportunity to identify 
chromosomal regions and eventually the specific genes that contribute to genetic 
variation in growth and its components feed intake and efficiency. The successful 
application of these markers to detect important loci affecting traits of interest requires a 
population in which the relevant alleles are segregating at those loci (Lander et al., 1989); 
An example of such a resource population is an F2 cross originating from grandparent 
stock that is phenotypically divergent for the traits of interest. The phenotypic and 
physiological divergence detected between the F and S lines in the present and previous 
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studies (Woltmann et al., 1992, 1995; Clutter et al., 1995) suggests the lines as candidates 
to produce a resource family in which loci contributing to variation in feed intake and 
growth can be identified. 
In summary, results from the present experiments revealed a tendency for greater 
plasma concentrations of CCK-8 in S than in F, and support the hypothesis that the line 
has been selected for slow growth, and that exhibits less appetite than the line selected for 
fast growth, has relatively greater circulating concentrations of CCK-8. Studies of the 
effects of infusion of exogenous CCK, CCK receptor antagonists, or CCK 
immunonuetralization on feed intake may provide a more complete picture of differences 
in CCK action between these selected lines. 
Although the results suggest that genetic differences in appetite between the lines 
are reflected in part by differences in CCK action, the relative contributions of individual 
genes or chromosomal regions to variation in appetite can only be determined in families 
in which the important gene forms are segregating. The F and S lines may be useful as 
parent or grandparent stock in the production of such a family. 
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CHAPTER IV 
FEEDING RESPONSE TO EXOGENOUS CHOLECYSTOKININ-8 IN PIGS 
WITH DIVERGENT GENETIC POTENTIAL FOR FEED INT AKE AND 
GROWTH 
Abstract 
The objective was to determine the effects of an eight amino acid molecular form 
of the satiety hormone cholecystokinin (CCK-8) on feed intake in lines of pigs with 
divergent genetic potential for feed intake and growth. After ten generations of selection 
for either fast (F) or slow (S) postweaning gain (ADG), overall daily feed intake and 
ADG were 36% and 47% greater in F than in S, respectively. It was hypothesized that the 
lower feed intake in S relative to F may be partly due to a greater sensitivity to feeding-
induced increases in CCK-8 in S than F pigs. Barrows from F and S restricted to zero 
growth during the experimental period were infused iv with O (saline), 60, 100, or 300 
ng/kg sulfated CCK-8 immediately before they were allowed ad libitum access to feed for 
2 hr. Individual feed intakes were determined at 10, 20, 30, 60, 90 and 120 min after 
introduction of feed. Blood samples were collected via jugular catheter at 30, 15, and 2 
min before and 10, 20, 30, 60, 90 and 120 min after introduction of feed. Plasma 
concentrations of CCK-8 were similar (P > 0.30) in F and S at each dosage of CCK-8. 
Feed consumption was reduced in both lines as dosage of CCK-8 increased, but the 
reduction at each dose was greater in S than F (P < 0.01). The dose of CCK-8 needed to 
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inhibit intake by 25% or 50% was less (P < 0.05) in S (D25 = 56.6 ng/kg; D50 = 146.47 
ng/kg) than in F (D25 = 94.9 ng/kg; D50 = 745.58 ng/kg) pigs. These results indicate that 
the genetic difference between these lines for appetite may be due in part to a difference 
in sensitivity to the CCK-8 satiety signal. 
Introduction 
The peptide hormone CCK is synthesized via the preprohormone pathway and 
exists in different molecular forms. To date, 58, 39, 33, 22, or 8 amino acid forms have 
been identified in tissues and blood of pigs (Crawley et al., 1994). The C-terminal 
sulfated octapeptide sequence, Aps-Tyr(S03H)-Met-Gly-Try-Met-Asp-Phe-NH2 (CCK-
8), is relatively conserved across species. CCK-8 appears to be the minimum sequence 
necessary for the biological activity (Crawley et al.,1994) and the most biologically 
potent form of CCK for the satiety effects (Reidelberger, 1994). The hypothesis that CCK 
functions as a satiety signal was first based on the reduction in feed intake of rats that 
received systemic injections of CCK (Gibbs et al., 1973). Since then, physiological 
evidence from studies of both agonists and antagonists have supported this hypothesis in 
many species (Morley, 1985, 1995; Silver et al., 1990; Baldwin et al., 1992; Parrott, 
1993). Agonists for CCK-8 or CCK-33 decreased feed intake (Baile et al., 1981; Morley, 
1985, 1995) and antagonists for CCK-8 or CCK-33 increased feed intake (Baile et al., 
1981; Baldwin et al., 1992; Ebenezer et al., 1990; Silver et al., 1990). Exogenous CCK-8 
inhibits feed intake in a variety of species including sheep (Della-Fera et al., 1979), rats 
(Joyner et al., 1993), mice (Silver et all., 1989), goldfish (Himick et al., 1994), baboons 
(Figlewics et al., 1992), chickens (Covasa et al., 1994), humans (Kissileff et al., 1981) 
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and pigs (Anika et al., 1981). Intravenous injection of CCK-8 (Anika et al., 1981; 
Baldwin et al., 1982) and CCK-A agonists (Parrott, 1993) decreased feed intake in pigs. 
Specific antagonists for CCK-A receptors (Ebenezer et al., 1990; Baldwin et al., 1992, 
1994) and immunoneutralization of circulating CCK-8 (Pekas et al., 1993) also have been 
shown to increase feed intake in pigs. 
Studies of the genetic basis for the relationship between CCK and appetite 
regulation have been limited to obese rodent strains. The total CCK content of brains of 
ob/ob mice was lower than that of their OBI- contemporaries (Straus et al., 1979). Zucker 
obese (fa/fa) rats expressed greater total CCK concentrations in hypothalamus during 
feeding, but lesser sensitivity to satiety effects of CCK (Moos et al., 1982). OLEFT rats 
increased CCK-8 concentrations in plasma during feeding, but failed to response to 
satiety effects of exogenous CCK-8 (Miyasaka et al., 1994). In each case the inheritance 
of obesity is due to a single gene effect. However, the relationship between normal 
genetic variation in feed intake and CCK has not been reported. 
Our laboratory has lines of pigs that have been undergone ten generations of 
divergent selection for either fast (F) or slow (S) postweaning average daily gain (ADG). 
Evaluation of results from the generation ten revealed that F pigs ate more (36% per day) 
and grew faster (47% per day) than S pigs (Clutter et al., 1997). Less appetite in S than in 
F may be in part due to more satiety effects of CCK-8 in S. This may be caused either by 
greater plasma CCK-8 in S than F or by changed/unchanged plasma concentrations of 
CCK-8 together with greater cellular response (i.e., satiety) to CCK-8 activation of CCK 
receptors involved with regulation of appetite in S than in F. Results reported in Chapter 
III indicated greater plasma concentrations of CCK-8 in S than in F barrows at the a. level 
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of 0.07 and suggested that CCK satiety action may play a role in genetic differences 
between the lines for feed intake. The objective of present investigation was to determine 
if pigs with divergent genetic potential for feed intake differ in feed consumption in 
response to infusion with exogenous CCK-8. The hypothesis was that the genetic 
differences for appetite between the lines is due in part to differences in sensitivity to the 
CCK-8 satiety signal. 
Materials and Methods 
Selection Lines and Sampling of Lines 
A study was initiated in 1979 to investigate direct and correlated response to 
divergent selection for ADG. The lines have undergone 10 generations of selection. 
Animals for the present experiments were sampled from F and S litters of the 10th 
generation in the first two consecutive sets of progeny from selected parents (fall 1993 
and spring 1994). The establishment of the selection lines, selection procedures and 
methods used to sample the lines for present experiment were described in detail in 
Chapter III. 
Experimental Procedures 
The same barrows as in experiments 1 and 2 (Chapter III) were used to determine 
efficacy of exogenous CCK-8 on satiety response in ad libitum fed F and S pigs. Animals 
continued to be fed for zero growth after experiments 1 and 2 (Chapter III) and allowed a 
48 hr acclimation period for this experiment. Each pig within a line was assigned 
randomly to one of the 24 sequences possible for four CCK-8 dosages of O (saline), 60, 
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100 or 300 ng/kg/min. The first dose was administered on the morning after the 48 hr 
acclimation period and at least 2 d separated successive doses. Doses of CCK-8 were 
infused (1 ml/min) via the jugular catheter for 12 min using a Harvard Model 22 infusion 
pump. Each infusion began 2 min before pigs were allowed ad libitum access to feed for 
2 hr. 
Individual feed intakes were determined at 10, 20, 30, 60, 60, 90 and 120 min 
after introduction of feed. Feed intakes during saline infusion established the control meal 
size for each animal. Methods used to collect individual feed intake data were the same as 
described in Chapter III. 
Blood samples were collected via jugular catheter at 30, 15, and 2 min before and 
10, 20, 30, 60, 90 and 120 min after introduction of feed. Blood samples (10 ml) were 
immediately transferred into glass tubes containing a 100 µl mixture of benzamidine (200 
mg/ml) and heparin (500 IU/ml) that were held in an ice-water bath. Chilled blood 
samples were centrifuged for 10 min (1,500 x g) at 4 °C and recovered plasma samples 
were stored at -20 °C until assayed. Thirteen barrows from F and nine from S of the fall 
1993 and spring 1994 farrowing groups completed the present study. 
The details for plasma extraction and radioimmnoassay (RIA) procedures as well 
as the validation of the CCK-8 RIA were described in Chapter III. To evaluate CCK-8 
concentrations within the range of standard curve, reconstituted plasma samples of some 
time intervals were diluted by assay buffer before RIA. For the 60 ng/kg/min dosage, 
reconstituted plasma samples of 10 and 20 min after feeding were diluted to 1 : 5 and 1 : 
2, respectively. For the 100 ng/kg/min dosage, reconstituted plasma samples of 10, 20 
and 30 min after feeding were diluted to 1 : 10, 1 : 5 and 1 : 2, respectively. For the 300 
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ng/kg/min dosage, the ratios of dilution for samples of 10, 20 and 30 min were 1 : 20, 1 : 
10 and 1 : 5, respectively. 
Calculations and Statistical Analysis: 
Methods of least-squares analysis used for data from the present experiment were 
as follows. Plasma concentrations of CCK-8 at each of the interval time relative to 
introduction of feed and cumulative feed intake at 10, 20, 30, 60, 90 and 120 min during 
the feeding period were analyzed with a model that included the effects of farrowing 
group (fall 1993 or spring 1994), line, dosage, and all associated interactions, animal 
within farrowing group x line x dosage, time and all interactions of time with line, dosage 
and farrowing group. Effects of farrowing group, line, dosage and two- and three-way 
interactions of farrowing group, line and dosage were tested using animal within 
farrowing group x line x dosage as the error term. Effects of time and associated 
interactions were tested using the residual as the error term. 
In addition to analysis of individual CCK-8 concentrations, areas under the curve 
for CCK-8 concentrations were calculated for each animal in the experiment by trapezoid 
method. Basal CCK-8 was based on the average of the three concentrations at -30, -15 
and -2 min. Response area in CCK-8 was the difference between total area under the 
curve and the basal area. Values for basal CCK-8, response in CCK-8 and total CCK-8 
were analyzed with a model that included the effects of farrowing group, line, dosage and 
all interactions. 
Maximum decrement in intake occurred at 10 to 20 min after infusing 60, 100, 
and 300 ng/kg CCK-8. Intakes at 10 and 20 min after feeding were averaged for each 
dose of CCK-8 and the average values were used in data analysis. Average intakes at 10-
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20 min after 60, 100 and 300 ng/kg CCK-8 infusion were expressed as percent of 
corresponding control intake after O ng/kg CCK-8 infusion. The relationship between 
percent of control intake and log dose of CCK-8 were analyzed by polynomial regression 
analysis (Fig.P, BioSoft, Durham, NC, USA). Comparisons of regression residual sum-
of-squares and coefficient of determination determined that a first degree polynomial best 
described the dose-response effect of CCK-8 on acute intake in F and S pigs. Doses of 
CCK-8 inhibiting intake by 25% (D25) and 50% (D50) were calculated using the equations 
derived from regression analysis of the mean data in each group of pigs. Significance of 
difference in the mean D25 and D50 doses were determined using the 95% confidence 
interval range for each estimate. 
Results 
For the control groups (saline infusion), least-squares means for CCK-8 
concentrations in plasma and for cumulative intakes are both presented in Figure 1. CCK-
8 concentrations in plasma increased in response to feeding and saline in both F and S, 
but no significant differences were observed between the lines (P > 0.40). Intake after the 
control infusion of saline was greater (P < 0.01) in F than S throughout the 2 hr feeding 
period. 
For the infusion groups, least-squares means for CCK-8 concentrations in plasma 
and for cumulative feed intake are plotted in Figure 2 to 4. CCK-8 concentrations in 
plasma were significantly affected by the infusion doses (P < 0.01) and time of feeding (P 
< 0.01) as well as by the dosage x time interaction (P < 0.01). Differences in plasma 
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Figure 1. Mean cumulative feed intakes and CCK-8 concentrations in plasma in F and S 
treated with saline and allowed ad libitum intake for 2 hr. Pigs were fasted for hr before 
the introduction of feed at time 0. 
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Figure 2. Cumulative feed intakes and CCK-8 concentrations in plasma from F and S pigs 
treated with 60 ng/kg of CCK-8 and fed ad libitum. Note the log scale on Y-axis for 
plasma CCK-8. 
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Figure 3. Cumulative feed intakes and CCK-8 concentrations in plasma from F and S pigs 
treated with 100 ng/kg of CCK-8 and fed ad libitum. Note the log scale on Y-axis for 
plasma CCK-8. 
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Figure 4. Cumulative feed intakes and CCK-8 concentrations in plasma from F and S pigs 




Table 1. LEAST-SQUARES MEANS FOR BASAL PLASMA CONCENTRATIONS OF 
CCK-8, RESPONSE AREAS IN CCK-8 AND TOTAL CCK-8 CALCULATED 
FROM THE AREA UNDER EACH CURVEa. 
CCK-8 (nglml · min} 
Basal Response Total 
0 ng/kg/minb 
F 317.18 ± 81.98c 1108.07 ± 334.37 1425.24 ± 376.99 
s 321.20 ± 85.02 618.32 ± 138.48 939.52 ± 170.85 
60 ng/kg/min 
F 331.86 ± 38.82 3607.07 ± 479.46 3938.94 ± 488.56 
s 434.80 ± 64.63 4369.98 ± 431.44 4554.78 ± 392.32 
100 ng/kg/min 
F 429.09 ± 61.77 9255.32 ± 1321.75 9684.41 ± 1277.30 
s 383.90 ± 61.44 8479.10 ± 564.68 8844.20 ± 534.57 
300 ng/kg/min 
F 456.48 ± 77.78 15419.35 ± 2003.47 15875.95 ± 2011.08 
s 453.00 ± 61.22 15379.58 ± 1271.53 15832.58 ± 1244.01 
aTrapezoid method. 
1nosage for infusion of exogenous CCK-8. 
cLeast-square mean ± SE. 
CCK-8 concentrations between lines were not detected (P = 0.40). Results of the analysis 
of basal CCK-8 and feeding-induced responses in CCK-8 are presented in Table 1. No 
significant differences in basal CCK-8 and response in CCK-8 detected between the lines 
(P = 0.12). 
To allow comparison of the effects of CCK-8 in F and S pigs, cumulative intakes 
during the experimental period were recalculated as percentage of corresponding control 
intakes at each time point (Figure 5). Significant dose-dependent and time-dependent 
inhibitory effects of CCK-8 on intake were observed in both F and S line (P < 0.01). 
There were dosage x time and dosage x line interactions. Response to each dosage, 
averaged across the 2 hr feeding period, is shown in Figure 6. Increasing dosage of CCK-
8 decreased intake in both lines, but by a significant greater amount in the S than in the F 
line (P < 0.01 ). 
Maximum inhibition of intakes occurred during the first 20 min after infusion of 
any of the three doses of CCK-8 in both F and S (Figure 5). The dose-response curves of 
CCK-8 effect on feed intake are presented in Figure 7. The significant (P < 0.05) best fit 
regression line in F was Y= - 27.92 (log dose) + 130.20 and that in S pigs was Y= -
60.57 (log dose) + 181.18. CCK-8 dosages suppressing mean intake by 25% (D25) and 
50% (D50) were calculated from these equations and were less (P < 0.05) in S (D25 = 56.6 
ng/kg; D50 = 146.5 ng/kg) than in F (D25 = 94 7 ng/kg; D50 = 745 ng/kg) pigs (Figure 8). 
The results indicate a greater sensitivity in S than in F pigs to CCK-8. 
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Time Relative to Introduction of Feed, min. 
Figure 5. Mean percent cumulative intakes during the 2 hr of ad libitum feeding in F and S 
pigs treated with CCK-8. Intakes at each time point expressed as percent of corresponding 
intake after Ong/kg CCK-8. 
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Figure 7. Dose-response effect of CCK-8 on acute (20 min) feed intake in F and S pigs. 
74 
Discussion 
Results reported in Chapter III revealed that the cumulative feed consumption of 
barrows from F was greater than from S and CCK-8 concentrations in plasma in S tended 
to be higher than in F barrows. These results suggested CCK satiety action may play a 
role in genetic differences for appetite between the selection lines. The results from the 
present study again confirmed that the divergent selection for ADG may have targeted 
genes involved CCK satiety action pathways. 
In the present studies, significant dose-dependent and time-dependent inhibitory 
effects of CCK-8 on intake were observed in F and S (Figure 7). These results are in 
agreement with previous reports in pigs (Anika et al., 1981; Houpt et al., 1979, Baldwin 
et al., 1982). 
Feed consumption was reduced in both lines as dosage of CCK-8 increased, but 
the reduction was greater in S than in F. Maximum inhibition of intakes occurred during 
the first 20 min after infusion of either of the three doses of CCK-8 in both lines. These 
results are consistent with the suggestion that CCK-8 acts as an acute, short term satiety 
signal (Reidelberger, 1994; Morley, 1995). Calculated dose of CCK-8 suppressing mean 
intake by 25% or 50% was less in S than in F pigs. This dose range was in agreement 
with another report in which 67 ng/kg CCK-8 infused into the jugular vein in pigs 
suppressed intake by 35% (Houpt et al., 1979). 
The present results indicated a greater sensitivity in S than in F pigs to CCK-8. 
The relatively greater inhibitory effects of CCK-8 in S than F pigs were associated with 
similar plasma concentrations and patterns of CCK-8 in both S and F after infusion of 
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either 60, 100 or 300 ng/kg dose of CCK-8. Similar results were reported in obese men 
(Kissileff et al., 1981 ), obese mice (Strohmayer et al., 1981; MaLaughlin et al., 1981) and 
obese Zucker rats (McLaughlin et al., 1980) in which obese individuals expressed a 
decrease in sensitivity to satiety-inducing effects of CCK-8. Thus, decreased sensitivity to 
CCK, which appears to be exhibited by obese animals, may be a cause or consequence of 
obesity and increased meal size (Baile et al., 1986). 
Taken together, results from the present experiments indicate that the genetic 
difference between these lines for appetite may be partly due to a difference in sensitivity 
to this satiety signal. Metabolic clearance of the infused CCK-8 may be similar in both 
lines because of the similar concentrations and patterns of plasma CCK-8 in Sand F pigs. 
The differences in sensitivity to satiety action of CCK may be caused by differences in 
DNA frequencies encoded in the genes for CCK receptors (CCKAR or CCKBR) 
involved with regulation of appetite. To obtain a more complete picture of the CCK 
action in genetic variation between F and S on protein levels, additional experiments to 
determine effects of specific CCK receptor antagonists, CCK immunoneutralization, 
distribution patterns and molecular forms of CCK (HPLCIRIA) on feed intake in F and S 
are necessary. 
Direct and correlated responses to selection are due to changes in the frequencies 
of gene alleles affecting each of the measured traits (Falconer, 1989). In pigs, genetic 
correlation of ADG with daily feed intake is quite high (Buchanan et al., 1993). Selection 
for ADG, and indirectly for feed intake, has no doubt targeted the alleles of many genes 
involving in feeding control pathway. Results from Chapter III and from the present 
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experiment suggest that the CCK gene and genes encoding CCK receptors may be 
targeted by the selection for ADG in pigs. 
Current approaches for genome analysis in porcine (Archibald et al., 1995; Rohrer 
et al., 1995) provide opportunity to identify the molecular basis of genetic variation in 
growth, feed intake and efficiency. To detect important loci that influence traits of 
interest, the first step is to establish a resource family in which the relevant alleles are 
segregating at those loci (Lander et al., 1989). The phenotypic and physiological 
divergence detected between the F and S lines in the present and previous studies 
(Woltmann et al., 1992, 1995; Clutter et al., 1995) suggest that the F and S lines can be 
used to produce a resource family to search for loci contributing to variation in feed 
intake and growth. 
In summary, results from the present experiments reveal a greater sensitivity to 
CCK-8 in S than in Fin suppressing feed intake and support the hypothesis that the line 
selected for fast growth has lesser sensitivity to the satiety effects of CCK-8. At the DNA 
level, further studies are needed to determine the relative contributions of the CCK gene 
and CCK receptor genes to variation in appetite in resource families in which alleles of 
these genes are segregating. 
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CHAPTERV 
RELATIONSHIP OF CHOLECYSTOKININ GENOTYPES WITH GROWTH 
AND BACKFAT IN OFFSPRING OF SIRES PRODUCED BY THE CROSS OF 
GENETICALLY DIVERGENT LINES 
Abstract 
The objective of this study was to identify relationships of a marker for the CCK 
gene with postweaning average daily gain (ADG) and 10th rib backfat thickness (BF) in a 
population of swine. Two families were produced using F 1 sires obtained from the cross 
of lines divergently selected for either fast or slow ADG. Two F 1 sires (A and B) were 
each mated to 15.unrelated dams and produced 147 and 132 offspring, respectively, in the 
resulting half-sib families. Alleles of the marker for the CCK gene located on 
chromosome 13 were significantly associated with ADG in the family of sire A (P < 
0.02), but not in the family of sire B. There was a tendency for relationship between 
alleles of the CCK marker and BF in the family of sire A (P < 0.1), but not in the family 
of sire B. Our results suggested that there may be a QTL for ADG on chromosome 13. 
Further analyses of the family of sire A, using additional markers in the region of the 
CCK gene are necessary to verify that a QTL is present and, if so, to more closely 
determine its position. 
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Introduction 
Swine breeders have used traditional methods ( e.g., phenotypic selection) to make 
considerable genetic advancement in some performance traits. Genetic improvement of 
production efficiency may be enhanced by molecular marker-assisted selection (MAS) 
(Soller, 1994; Weller, 1996). Molecular marker-assisted selection will first require 
identification of candidate genes or anonymous genetic markers associated with 
important traits. Only a few studies have shown associations of genes or anonymous 
markers with quantitative trait loci (QTL) in pigs (e.g., Jung et al., 1989; Clamp et al., 
1992; Andersson et al., 1994; Yu et al., 1995; Rothschild et al., 1995). Studies designed 
to determine the association of specific genes with genetic variation in traits of interest 
(i.e., "the candidate gene approach'') are justified when the genes are known to have 
functions related to characteristics of production or reproduction. 
Feed efficiency is one of the major factors that determine the profitability of the 
swine industry, but traditional methods of genetic improvement in feeding efficiency 
have be hampered by the cost of measuring individual feed intake. A better 
understanding of the genetic control of appetite regulation on DNA level may lead to the 
development of more effective selection methods ( e.g., MAS). 
The hormone CCK has been reported to play a role in appetite regulation in 
various species including pigs (Anika et al., 1981; Della-Fera et al., 1979; McLaughlin et 
al., 1985). Specific antagonists for CCK receptors (Ebenezer et al., 1990; Baldwin et al., 
1992), and specific immunoneutralization of circulating CCK-8 (Pekas et al., 1993), have 
resulted in increased feed consumption in pigs. Our previous studies of physiological 
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divergence of fast (F) or slow (S) growth selection lines of pigs revealed a tendency for 
greater plasma concentrations of CCK-8 (Chapter III) and a greater sensitivity in response 
to exogenous CCK-8 in S than in F barrows (Chapter IV), both results consistent with the 
relative feed consumptions of the lines. Thus, CCK action may play a role in the genetic 
differences in appetite between F and S. However, these physiological evaluations of 
selection lines only provide a picture of the genetic differences at the protein level. The 
relative contributions of the CCK gene to variation in appetite and growth can only be 
determined in families in which markers for the CCK gene are segregating. The 
phenotypic and physiological divergence detected between the F and S lines in the 
present and previous studies (Woltmann et al., 1992, 1995; Clutter et al., 1995) suggests 
the lines as candidates to produce a resource family in which loci contributing to variation 
in feed intake and growth can be identified. 
The objective of the present study was to examine the contribution of 
chromosomal reg10ns linked to the CCK gene to variation in growth and body 
composition in the offspring of F 1 sires produced by the cross of the F and S selection 
lines. 
Materials and Methods 
Resource Families 
Half-sib families were produced by mating two F 1 sires (A and B) each with 15 
unrelated sows at the University of Wisconsin-Platteville Swine Center. Both sires were 
obtained from the cross of lines divergently selected for either fast or slow ADG for 10 
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generations (Woltmann et al., 1992; Clutter et al., 1995). A total of 147 and 132 
offspring, respectively, were produced in the half-sib families. 
Phenotypic Traits 
Offspring were evaluated for ADG, measured as the difference in live weight 
before slaughter (approximately 110 kg) and at weaning, divided by days from weaning 
to slaughter. This was also the sole selection criterion in the F and S lines (Woltmann et 
al., 1992). BF at the 10th rib was measured on cold carcasses 24 hr after slaughter, as an 
indicator of body composition. 
DNA analysis 
DNA samples in the study were obtained from a collaborative laboratory at 
University of Wisconsin-Madison. Working dilutions of extracted DNA were obtained 
for each individual at a concentration of 50 ng/µl. Methods of animal handling, DNA 
extraction and preparation have been described by Casas-Carrillo et al. (1997ab). 
The marker for the CCK gene was previously described by Clutter et al. (1996). 
Briefly, the primers used to amplify the porcine CCK gene were designed on the basis of 
the exon/intron organization of the human and mouse CCK genes (Takahashi et al., 1985, 
1986; Vitale et al., 1991) and porcine cDNA sequences (Gubler et al., 1984) and were to 
flank an expected intron of-4 to 6 kb. Primer sequences were: 
5'-primer, 5'-CTGGCCAGATACATCCAGCA-3'; 
3 '-primer, 5' -ATCCATCCAGCCCATGTAGT-3 '. 
Polymerase chain reaction (PCR) [25 µl final volume] was performed using 50 ng 
genomic DNA, 1 mM Mg(OAc)z, 200 µMeach dNTP, 0.35 µMeach primer, 0.4 units 
rTth DNA polymerase-XL (Perkin-Elmer) and its supplied buffer. A hot start was used 
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(polymerase added at 80 °C), and thermal cycling began with an initial cycle of 95 °C for 
1 min, 60 °C for 1 min and 72 °C for 5 min, followed by 34 cycles of94 °C for 30 sec, 60 
°C for 1 min and 72 °C for 5 min. The last 19 cycles included additional, cumulative 
extension periods of 15 sec per cycle. The reaction resulted in a single DNA product of 
-3.57 kb. Terminal end-sequencing was used to verify that the product includes the 
expected exon regions of the porcine CCK gene. Digestion of the PCR product by the 
restriction enzyme Dpnll produced a restriction fragment length polymorphism (RFLP) 
that could be used as a marker for the CCK gene. The genotypes of individuals were 
expressed as AA, AB and BB. Both sires (A and B) were heterozygous (AB) for the 
marker, which allowed the analysis of relationships between the CCK marker .and 
phenotypic traits in each of the half-sib families. 
Statistical analysis 
Inheritance of paternal alleles for CCK was coded as the probability of inheriting 
allele A from the sire (Dentine et al., 1990). Where paternal inheritance was 
unambiguous, this probability was either l or 0. In cases where the offspring was 
ambiguous, that is, their heterozygous genotype was identical to that of sire and dam, the 
probability of inheriting sire allele A was 0.5. These probabilities were used as regressors 
in the statistical model. Data for ADG and BF were analyzed separately for each sire 
group with least-squares procedures using the following model: 
Y ij = µ + Li + BmarkerXmarker + Ejj 
where: 
y.. 







= population mean, 
= effect of the i-th litter, 
= regression on probability of inheriting marker allele A from sire, 
= probability of inheriting marker allele A from sire, 
= random error. 
Results 
PCR products were obtained for 60 of 147 individuals in the family of sire A and 
36 of 132 individuals in the family of sire B. Due to missing phenotypic measurements, 
only 46 and 25 observations could be used in the analyses for the families of sire A and of 
sire B, respectively. 
There was a significant association between the inheritance of paternal marker 
alleles and ADG in the family of sire A (b = 0.032 ± 0.014 kg/d, p < 0.02). For the family 
of sire B, CCK genotypes were not associated significantly with ADG (b = 0.014 ± 0.022 
kg/d, p > 0.60). 
CCK marker genotypes tended to be associated with 10th rib BF in the family of 
sire A (b = 0.52 ± 0.31 cm, p < 0.1 ), but not in the family of sire B (b = 0.13 ± 0.51 cm, p 
> 0.80). 
Discussion 
The candidate gene approach is justified when genes previously identified in the 
species of interest or other species have functions related to the traits of interest. Several 
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studies have revealed associations of genes with growth traits in mice (Winkelman et al., 
1992; Pomp et al., 1994; Horvat et al., 1995; Keightley et al., 1996). In pigs, only a few 
studies have shown the associations of genes with quantitative traits. 
Clamp et al. (1992) reported the presence of gene(s) that affect rate of body 
weight gain linked to the glucose phosphate isomerase (GPI) loci on porcine chromosome 
6. In a study for detecting the relationships of growth hormone and insulin-like factor-I 
genotypes with growth and carcass traits in pig families, a potential association of IGFI 
genotype with ADG was observed and a QTL, closely linked to IGFl, may be located in 
the interval between Sw1071 and IGFl on chromosome 5 (Casas-Carrillo et al., 1997a). 
Significant associations of PITl genotypes with growth rate were detected; thus, PITl has 
been suggested to be a candidate gene for a QTL for growth on chromosome 13 (Yu et 
al., 1995). 
CCK has been established as a satiety hormone in the pig. However, the relative 
contribution of the CCK satiety action to variation in appetite and growth is still 
unknown. This could be verified by analyzing the associations between marker genotypes 
for CCK and CCK receptors with growth and feed intake traits in resource families in 
which there is segregation at loci contributing to variation in growth and feed intake. Due 
to the lack of phenotypic measurements for feed intake, only the relationship of CCK 
genotype with ADG and BF was evaluated in the present study. 
The CCK gene was reported to be located on porcine chromosome 13 (Clutter et 
al., 1996; Rettenberger et al., 1996). A briefly linkage map for chromosome 13 is 
presented in Figure 1. The CCK gene marker used in the study had no recombination 
with the Type I marker ITIH, was linked to the marker TF with a recombination 
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frequency of 0.19, and to microsatellite marker S0288 with recombination frequency of 
0.02 (Clutter et al., 1996). The frequencies of alleles of the marker for the CCK gene 
were not significant different between F and S (Clutter et al., 1996). 
A nominally significant association between the marker alleles and ADG and a 
tendency for association between the marker alleles and BF were observed in the family 
of sire A in present study. The results indicate that a potential QTL for ADG may be 
segregating in the region of the CCK gene on chromosome 13. The results are consistent 
with other studies in which potential QTLs for growth have been reported to be located 
on the porcine chromosome 13 in different resource families (Yu et al., 1995; Andersson 
et al., 1994). In the same resource families as used in the present investigation, however, 
no significant association of ADG with the genomic region on chromosome 13 was 
detected by scanning the genome with genetic markers (Casas-Carrillo et al., 1997b ). 
This result is in contrast with the present results. A limited number of markers used in 
their study may be one of the possible reasons for failing to detect the significant 
associations on chromosome 13. 
Although a significant association was detected in one family, the power for 
association detection was limited by the small amount of data due to unsuccessful PCR 
amplification and missing phenotypic measurements. Unsuccessful PCR may be due to a 
break down of the genomic DNA. Thus, additional work is needed to evaluate smaller 
size markers such as microsatellite markers which are in the chromosome region of the 































Figure 1. Linkage map of pig chromosome 13. Map distances ( cM) between markers are 
presented. The location of a potential ADG QTL was suggested to be in the region linked 




Genetic variation in appetite exists in animal populations. Better understanding of 
the genetic nature of appetite regulation may help development of more effective 
selection methods and better breeding programs for feed efficiency. Many animal models 
have been established to identify the molecular mechanisms of control of feed intake, 
regulation of body weight and development of obesity. However, all of these animal 
models are based on single gene mutations. Studies of normal quantitative genetic 
variation in feed intake and growth are rare. To our knowledge, no research has been 
reported to clarify the quantitative and molecular basis for variation in appetite regulation 
in normal animal populations using divergent selection lines as a model. 
In the present study, the selection lines of pigs with divergent potential in growth 
and feed intake were used to elucidate the role of satiety hormone CCK in appetite 
regulation. The genetic differences for appetite between the lines may be in part due to 
differences in satiety effects of CCK. Lesser satiety effects of CCK-8 in F than in Smay 
be caused by a lower concentration of plasma CCK-8 in F or by changed/unchanged 
plasma concentrations of CCK-8 together with decreased cellular response (i.e., CCK-8 
activation of CCK receptors involved with regulation of appetite). A tendency for greater 
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plasma concentration of CCK-8 and a significantly greater sensitivity to exogenous CCK-
8 in S than in F pigs was revealed in the present study. 
Although the importance of CCK-8 as a satiety signal in the pig has been implied 
through infusion studies, antagonists for CCK-8 and the immunoneutralization of 
circulating CCK-8, the relative effects of bioactive forms of CCK on feeding behavior 
remains to be determined. The effect of selection on relative changes of molecular forms 
of CCK in the present study can only be determined by additional work to separate 
peptide fractions (HPLCIRIA). In addition, experiments to determine the effects of CCK 
receptor antagonists and CCK immunoneutralization on feed intake in F and S may 
provide a more complete picture of the role of CCK action in genetic differences between 
the lines. 
To understand genetic variation in growth and body composition at the DNA 
level, resource families were produced by using the cross of the F and S selection lines as 
F 1 sires. A significant association was detected between the variation in ADG and a 
marker for the CCK gene. If this association is real, the effect may be due to alleles of the 
CCK gene or of some closely linked gene(s). 
Taken together, we concluded that the CCK satiety action plays a role in genetic 
variation in appetite in F and S and there may be a QTL for ADG in the chromosomal 
region of the CCK gene on chromosome 13. 
However, due to the complex and quantitative characteristics of feed intake, many 
loci probably contribute to genetic variation in appetite. For example, the frequencies of 
alleles of markers for the leptin gene and for the CCKAR gene were significant different 
between F and S, indicating that these loci may have been targets of selection and 
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contribute to genetic difference between the lines. Also, another potential QTL for ADG 
was detected on chromosome 3 in the family of one F 1 sire. Thus, additional work is 
necessary to learn more about genetic variation in feed intake. A genome scanning 
approach will be continued to identify important chromosomal regions affecting feed 
intake and efficiency. Then, the identified regions with suspected QTL or ETL for feed 
intake will be investigated using comparative mapping and positional candidates to try to 
identify the individual genes responsible for differences in appetite. Furthermore, the 
expression and function of relevant candidate genes at the molecular and physiological 
levels will be examined in detail. This multidisciplinary approach of positional candidate 
cloning and gene expression/function research will help to elucidate how genes affect 
feed intake and efficiency and how they can be manipulated for genetic improvement. 
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